-------------
sentence: Concomitant use with other calcium-containing medicines (including antacids) may cause too much calcium in the blood or urine, which may increase the chance of side effects.
entities: calcium / calcium
ddi: null
>>> match: cause_VB
-------------
sentence: Concomitant use with other calcium-containing medicines (including antacids) may cause too much calcium in the blood or urine, which may increase the chance of side effects.
entities: antacids / calcium
ddi: null
>>> match: cause_VB
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: histamine H2-receptor antagonists / IRESSA
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: ranitidine / IRESSA
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: cimetidine / IRESSA
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: IRESSA / vinorelbine
ddi: effect
>>> match: exacerbate_VB
-------------
sentence: FLUOTHANE augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides.
entities: FLUOTHANE / non-depolarising muscle relaxants
ddi: effect
>>> match: augment_VB
-------------
sentence: FLUOTHANE augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides.
entities: FLUOTHANE / aminoglycosides
ddi: effect
>>> match: augment_VB
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine. 
entities: terbinafine / tolbutamide
ddi: null
>>> match: inhibit_VB
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine. 
entities: terbinafine / ethinylestradiol
ddi: null
>>> match: inhibit_VB
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine. 
entities: terbinafine / ethoxycoumarin
ddi: null
>>> match: inhibit_VB
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine. 
entities: terbinafine / cyclosporine
ddi: null
>>> match: inhibit_VB
-------------
sentence: In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin. 
entities: terbinafine / antipyrine
ddi: null
>>> match: affect_VB
-------------
sentence: In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin. 
entities: terbinafine / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Terbinafine decreases the clearance of caffeine by 19%. 
entities: Terbinafine / caffeine
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Terbinafine increases the clearance of cyclosporine by 15%. 
entities: Terbinafine / cyclosporine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: However, L-NAME (100 and 300 micromol/l) did not alter the effects of reseveratrol on arteries from dietary-obese rats, giving superimposed concentration-responses curves. 
entities: L-NAME / reseveratrol
ddi: null
>>> match: alter_VB
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: gemfibrozil / rosiglitazone
ddi: mechanism
>>> match: increase_VB
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: gemfibrozil / rifampin
ddi: null
>>> match: increase_VB
-------------
sentence: Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.
entities: Tiagabine / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Carbamazepine: Tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy.
entities: Tiagabine / carbamazepine
ddi: null
>>> match: have_VB
-------------
sentence: Valproate: Tiagabine causes a slight decrease (about 10%) in steady-state valproate concentrations.
entities: Tiagabine / valproate
ddi: mechanism
>>> match: cause_VB
-------------
sentence: The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo.
entities: tiagabine / phenobarbital
ddi: null
>>> match: cause_VB
-------------
sentence: The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo.
entities: tiagabine / primidone
ddi: null
>>> match: cause_VB
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / tiagabine
ddi: null
>>> match: have_VB
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / tiagabine
ddi: null
>>> match: have_VB
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: Cimetidine / tiagabine
ddi: null
>>> match: have_VB
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: cimetidine / tiagabine
ddi: null
>>> match: have_VB
-------------
sentence: Theophylline: A single 10 mg dose of tiagabine did not affect the pharmacokinetics of theophylline at steady state.
entities: tiagabine / theophylline
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin.
entities: tiagabine / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin.
entities: tiagabine / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Tiagabine has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or alcohol.
entities: Tiagabine / alcohol
ddi: null
>>> match: show_VB
-------------
sentence: Oral Contraceptives: Multiple dose administration of tiagabine (8 mg/day monotherapy) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age.
entities: Contraceptives / contraceptives
ddi: null
>>> match: alter_VB
-------------
sentence: Oral Contraceptives: Multiple dose administration of tiagabine (8 mg/day monotherapy) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age.
entities: tiagabine / contraceptives
ddi: null
>>> match: alter_VB
-------------
sentence: This indicates that tiagabine does not cause induction or inhibition of the hepatic microsomal enzyme systems responsible for the metabolism of antipyrine.
entities: tiagabine / antipyrine
ddi: null
>>> match: cause_VB
-------------
sentence: PROSTIN E2 may augment the activity of other oxytocic drugs.
entities: PROSTIN E2 / oxytocic drugs
ddi: effect
>>> match: augment_VB
-------------
sentence: Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin
entities: Eszopiclone / (R)-warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin
entities: Eszopiclone / (S)-warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: RESULTS: Sildenafil has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy, radiation therapy, diabetes mellitus, certain neurologic disorders, and drug therapy (eg, selective serotonin reuptake inhibitors [SSRIs]). 
entities: Sildenafil / selective serotonin reuptake inhibitors
ddi: null
>>> match: demonstrate_VB
-------------
sentence: RESULTS: Sildenafil has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy, radiation therapy, diabetes mellitus, certain neurologic disorders, and drug therapy (eg, selective serotonin reuptake inhibitors [SSRIs]). 
entities: Sildenafil / SSRIs
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Co-treatment with the potent CYP3A4 inhibitor ketoconazole increases erlotinib AUC by 2/3.
entities: ketoconazole / erlotinib
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Pre-treatment with the CYP3A4 inducer rifampicin decreased erlotinib AUC by about 2/3.
entities: rifampicin / erlotinib
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: MAO inhibitors / antidepressant
ddi: null
>>> match: increase_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: MAO inhibitors / hydrocodone
ddi: null
>>> match: increase_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: tricyclic antidepressants / antidepressant
ddi: null
>>> match: increase_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: tricyclic antidepressants / hydrocodone
ddi: null
>>> match: increase_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: hydrocodone / antidepressant
ddi: null
>>> match: increase_VB
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: hydrocodone / hydrocodone
ddi: null
>>> match: increase_VB
-------------
sentence: After multiple dosing, interferon beta-1a (AVONEX  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.
entities: interferon beta-1a / TYSABRI
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: After multiple dosing, interferon beta-1a (AVONEX  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.
entities: AVONEX / TYSABRI
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: CYP3A4 Inhibitors: Ketoconazole, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions). 
entities: Ketoconazole / tolterodine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Gemfibrozil Other fibrates Niacin (nicotinic acid) (=1 g/day)
entities: Gemfibrozil / Niacin
ddi: null
>>> match: fibrate_VB
-------------
sentence: Gemfibrozil Other fibrates Niacin (nicotinic acid) (=1 g/day)
entities: Gemfibrozil / nicotinic acid
ddi: null
>>> match: fibrate_VB
-------------
sentence: The zidovudine study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine. 
entities: zidovudine / zidovudine
ddi: null
>>> match: dose_VB
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: Azithromycin / zidovudine
ddi: null
>>> match: have_VB
-------------
sentence: Azithromycin had no significant effect on dideoxyinosine pharmacokinetics. 
entities: Azithromycin / dideoxyinosine
ddi: null
>>> match: have_VB
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: Barbiturates / doxycycline
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: carbamazepine / doxycycline
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: phenytoin / doxycycline
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Ritalin may decrease the hypotensive effect of guanethidine. 
entities: Ritalin / guanethidine
ddi: effect
>>> match: decrease_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / coumarin anticoagulants
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / anticonvulsants
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / phenobarbital
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / diphenylhydantoin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / primidone
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / phenylbutazone
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / tricyclic drugs
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / imipramine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / clomipramine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / desipramine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Rofecoxib did not influence the plasma pharmacokinetics or renal elimination of a single oral dose of digoxin.
entities: Rofecoxib / digoxin
ddi: null
>>> match: influence_VB
-------------
sentence: Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.

entities: hydrocortisone / d-amphetamine
ddi: null
>>> match: affect_VB
-------------
sentence: However, hydrocortisone pretreatment did not affect any of the physiological, behavioral, or subjective effects of d-amphetamine. 
entities: hydrocortisone / d-amphetamine
ddi: null
>>> match: affect_VB
-------------
sentence: EDECRIN may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics.
entities: EDECRIN / aminoglycoside
ddi: effect
>>> match: increase_VB
-------------
sentence: EDECRIN may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics.
entities: EDECRIN / cephalosporin antibiotics
ddi: effect
>>> match: increase_VB
-------------
sentence: In some patients, the administration of a non- steroidal antiinflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium- sparing and thiazide diuretics.
entities: non- steroidal antiinflammatory agent / potassium- sparing diuretics
ddi: effect
>>> match: reduce_VB
-------------
sentence: In some patients, the administration of a non- steroidal antiinflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium- sparing and thiazide diuretics.
entities: non- steroidal antiinflammatory agent / thiazide diuretics
ddi: effect
>>> match: reduce_VB
-------------
sentence: Anticoagulants Anabolic steroids may increase sensitivity to oral anticoagulants. 
entities: Anticoagulants / anticoagulants
ddi: null
>>> match: increase_VB
-------------
sentence: Anticoagulants Anabolic steroids may increase sensitivity to oral anticoagulants. 
entities: Anabolic steroids / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Oral hypoglycemic agents Oxandrolone may inhibit the metabolism of oral hypoglycemic agents. 
entities: hypoglycemic agents / hypoglycemic agents
ddi: null
>>> match: inhibit_VB
-------------
sentence: Oral hypoglycemic agents Oxandrolone may inhibit the metabolism of oral hypoglycemic agents. 
entities: Oxandrolone / hypoglycemic agents
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_VB
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / alcohol
ddi: effect
>>> match: have_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / CNS depressants
ddi: effect
>>> match: have_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / hypnotics
ddi: effect
>>> match: have_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / sedatives
ddi: effect
>>> match: have_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / tranquilizers
ddi: effect
>>> match: have_VB
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / antianxiety agents
ddi: effect
>>> match: have_VB
-------------
sentence: Administration of valproic acid decreases oral clearance of temozolomide by about 5%. 
entities: valproic acid / temozolomide
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Use of a diuretic may further increase the risk of lithium toxicity. 
entities: diuretic / lithium
ddi: null
>>> match: increase_VB
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / barbiturates
ddi: effect
>>> match: increase_VB
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / tolbutamide
ddi: effect
>>> match: increase_VB
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / uricosurics
ddi: effect
>>> match: increase_VB
-------------
sentence: Oral contraceptives and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking nevirapine, since nevirapinemay lower the plasma levels of thesemedications.
entities: contraceptives / nevirapine
ddi: advise
>>> match: useda_VB
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / nevirapine
ddi: advise
>>> match: maintain_VB
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / barbiturates
ddi: effect
>>> match: enhance_VB
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: CNS depressant drugs / INAPSINE
ddi: effect
>>> match: have_VB
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: barbiturates / INAPSINE
ddi: effect
>>> match: have_VB
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: tranquilizers / INAPSINE
ddi: effect
>>> match: have_VB
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: opioids / INAPSINE
ddi: effect
>>> match: have_VB
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: anesthetics / INAPSINE
ddi: effect
>>> match: have_VB
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: inhibit_VB
-------------
sentence: Although no studies have been conducted, concomitant administration of Itraconazole and phenytoin may alter the metabolism of phenytoin;
entities: Itraconazole / phenytoin
ddi: null
>>> match: alter_VB
-------------
sentence: Although no studies have been conducted, concomitant administration of Itraconazole and phenytoin may alter the metabolism of phenytoin;
entities: phenytoin / phenytoin
ddi: null
>>> match: alter_VB
-------------
sentence: It has been reported that Itraconazole enhances the anticoagulant effect of coumarin-like drugs.
entities: Itraconazole / coumarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_VB
-------------
sentence: Verapamil also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by bombesin. 
entities: Verapamil / bombesin
ddi: effect
>>> match: decrease_VB
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / theophylline
ddi: null
>>> match: have_VB
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / digoxin
ddi: null
>>> match: have_VB
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / ethinylestradiol
ddi: null
>>> match: have_VB
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / contraceptive product
ddi: null
>>> match: have_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: FACTIVE / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: calcium carbonate / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: cimetidine / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: omeprazole / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: estrogen / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: progesterone / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: contraceptive / gemifloxacin
ddi: null
>>> match: produce_VB
-------------
sentence: FACTIVE had no significant effect on the anticoagulant effect of warfarin in healthy subjects on stable warfarin therapy.
entities: FACTIVE / warfarin
ddi: null
>>> match: have_VB
-------------
sentence: FACTIVE had no significant effect on the anticoagulant effect of warfarin in healthy subjects on stable warfarin therapy.
entities: FACTIVE / warfarin
ddi: null
>>> match: have_VB
-------------
sentence: Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.
entities: propranolol / ergotamine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: MTX / abatacept
ddi: null
>>> match: influence_VB
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: NSAIDs / abatacept
ddi: null
>>> match: influence_VB
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: corticosteroids / abatacept
ddi: null
>>> match: influence_VB
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: TNF blocking agents / abatacept
ddi: null
>>> match: influence_VB
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / tricyclics
ddi: effect
>>> match: increase_VB
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / amphetamines
ddi: effect
>>> match: increase_VB
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / procainamide
ddi: effect
>>> match: increase_VB
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / quinidine
ddi: effect
>>> match: increase_VB
-------------
sentence: Interactions for Vitamin B2 (Riboflavin):  Alcohol - impairs the intestinal absorption of riboflavin
entities: Alcohol / riboflavin
ddi: mechanism
>>> match: impair_VB
-------------
sentence: Probenecid - concurrent use decreases gastrointestinal absorption of riboflavin; 
entities: Probenecid / riboflavin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Probenecid: The oral combination of probenecid before intramuscular injection of PIPRACIL produces an increase in piperacillin peak serum level of about 30%.
entities: probenecid / piperacillin
ddi: null
>>> match: produce_VB
-------------
sentence: Probenecid: The oral combination of probenecid before intramuscular injection of PIPRACIL produces an increase in piperacillin peak serum level of about 30%.
entities: PIPRACIL / piperacillin
ddi: null
>>> match: produce_VB
-------------
sentence: Methotrexate: Piperacillin sodium may reduce the excretion of methotrexate.
entities: Piperacillin sodium / methotrexate
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: antacids / fosinopril
ddi: mechanism
>>> match: impair_VB
-------------
sentence: Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for Digoxin.
entities: Fosinopril / digoxin
ddi: null
>>> match: cause_VB
-------------
sentence: Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for Digoxin.
entities: Fosinopril / Digoxin
ddi: null
>>> match: cause_VB
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: phenytoin / flecainide
ddi: mechanism
>>> match: indicate_VB
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: phenobarbital / flecainide
ddi: mechanism
>>> match: indicate_VB
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: carbamazepine / flecainide
ddi: mechanism
>>> match: indicate_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / digoxin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / procainamide
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / pancuronium
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / morphine
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / vancomycin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / metformin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / tenofovir
ddi: mechanism
>>> match: have_VB
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: anticonvulsants / mifepristone
ddi: mechanism
>>> match: induce_VB
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenytoin / mifepristone
ddi: mechanism
>>> match: induce_VB
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenobarbital / mifepristone
ddi: mechanism
>>> match: induce_VB
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: carbamazepine / mifepristone
ddi: mechanism
>>> match: induce_VB
-------------
sentence: Diuretic agents may decrease vascular response to pressor drugs such as epinephrine.
entities: Diuretic agents / epinephrine
ddi: effect
>>> match: decrease_VB
-------------
sentence: Epinephrine may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter.
entities: Epinephrine / guanethidine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Addition or deletion of any drug from the therapeutic regimen of patients receiving oral anticoagulants may affect patient response to the anticoagulant.
entities: anticoagulants / anticoagulant
ddi: null
>>> match: affect_VB
-------------
sentence: For example, since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin K, the net effects are unpredictable.
entities: cholestyramine / anticoagulants
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: For example, since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin K, the net effects are unpredictable.
entities: cholestyramine / vitamin K
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Chloral hydrate may cause an increased prothrombin response by displacing the anticoagulant from protein binding sites or a diminished prothrombin response through increased metabolism of the unbound drug by hepatic enzyme induction, thus leading to inter-patient variation in ultimate prothrombin effect.
entities: Chloral hydrate / anticoagulant
ddi: mechanism
>>> match: cause_VB
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / hypoglycemic agents
ddi: mechanism
>>> match: potentiate_VB
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / tolbutamide
ddi: mechanism
>>> match: potentiate_VB
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / chlorpropamide
ddi: mechanism
>>> match: potentiate_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: aspirin / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: non-steroidal anti-inflammatory drugs / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: dipyridamole / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: hydrochloroquine / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: clofibrate / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: dextran / anticoagulants
ddi: effect
>>> match: increase_VB
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: NaCMC / NaFlu
ddi: null
>>> match: have_VB
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: cysteine / NaFlu
ddi: null
>>> match: have_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / NaFlu
ddi: null
>>> match: improve_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / bacitracin
ddi: null
>>> match: improve_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / insulin
ddi: null
>>> match: improve_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / NaFlu
ddi: null
>>> match: improve_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / bacitracin
ddi: null
>>> match: improve_VB
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / insulin
ddi: null
>>> match: improve_VB
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / phenobarbital
ddi: effect
>>> match: counteract_VB
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / phenytoin
ddi: effect
>>> match: counteract_VB
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / primidone
ddi: effect
>>> match: counteract_VB
-------------
sentence: However, high doses of leucovorin may reduce the efficacy of intrathecally administered methotrexate.
entities: leucovorin / methotrexate
ddi: effect
>>> match: reduce_VB
-------------
sentence: Leucovorin may enhance the toxicity of 5-fluorouracil.
entities: Leucovorin / 5-fluorouracil
ddi: effect
>>> match: enhance_VB
-------------
sentence: Propranolol increases hydralazine's serum concentrations.
entities: Propranolol / hydralazine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: NSAIDs may decrease the hemodynamic effects of hydralazine;
entities: NSAIDs / hydralazine
ddi: effect
>>> match: decrease_VB
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: Urinary acidifying agents / amphetamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: ammonium chloride / amphetamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: sodium acid phosphate / amphetamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Urinary alkalinizing agents (acetazolamide, some thiazides) increase the concentration of the non-ionized species of the amphetamine molecule, thereby decreasing urinary excretion.
entities: acetazolamide / amphetamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Urinary alkalinizing agents (acetazolamide, some thiazides) increase the concentration of the non-ionized species of the amphetamine molecule, thereby decreasing urinary excretion.
entities: thiazides / amphetamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Antidepressants, tricyclic: Amphetamines may enhance the activity of tricyclic or sympathomimetic agents;
entities: Amphetamines / tricyclic
ddi: effect
>>> match: enhance_VB
-------------
sentence: Antidepressants, tricyclic: Amphetamines may enhance the activity of tricyclic or sympathomimetic agents;
entities: Amphetamines / sympathomimetic agents
ddi: effect
>>> match: enhance_VB
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: d-amphetamine / d-amphetamine
ddi: null
>>> match: cause_VB
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: desipramine / d-amphetamine
ddi: null
>>> match: cause_VB
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: protriptyline / d-amphetamine
ddi: null
>>> match: cause_VB
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: tricyclics / d-amphetamine
ddi: null
>>> match: cause_VB
-------------
sentence: Antihistamines: Amphetamines may counteract the sedative effect of antihistamines.
entities: Amphetamines / antihistamines
ddi: effect
>>> match: counteract_VB
-------------
sentence: Antihypertensives: Amphetamines may antagonize the hypotensive effects of antihypertensives.
entities: Amphetamines / antihypertensives
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Ethosuximide: Amphetamines may delay intestinal absorption of ethosuximide.
entities: Amphetamines / ethosuximide
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Meperidine: Amphetamines potentiate the analgesic effect of meperidine.
entities: Amphetamines / meperidine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Norepinephrine: Amphetamines enhance the adrenergic effect of norepinephrine.
entities: Amphetamines / norepinephrine
ddi: effect
>>> match: enhance_VB
-------------
sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;
entities: Amphetamines / phenobarbital
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;
entities: Amphetamines / phenytoin
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Veratrum alkaloids: Amphetamines inhibit the hypotensive effect of veratrum alkaloids.
entities: Amphetamines / veratrum alkaloids
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Drug/Laboratory Test Interactions: Amphetamines can cause a significant elevation in plasma corticosteroid levels.
entities: Amphetamines / corticosteroid
ddi: effect
>>> match: cause_VB
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: anticholinesterases / procaine hydrochloride
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Hyaluronidase: Hyaluronidase may increase the diffusion rate of procaine hydrochloride, resulting in a decreased time of onset, but an increase in systemic toxicity. 
entities: Hyaluronidase / procaine hydrochloride
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Acetazolamide: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of procaine.
entities: acetazolamide / procaine
ddi: null
>>> match: extend_VB
-------------
sentence: Acetazolamide: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of procaine.
entities: procaine hydrochloride / procaine
ddi: null
>>> match: extend_VB
-------------
sentence: The uptake inhibitors cocaine and desipramine (3 mumol/liter) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium. 
entities: cocaine / norepinephrine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: The uptake inhibitors cocaine and desipramine (3 mumol/liter) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium. 
entities: desipramine / norepinephrine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Radioligand binding experiments using the uptake inhibitor hydrogen-3 mazindol revealed a significant decrease by approximately 30% in norepinephrine uptake-1 carrier density in functional classes II to III and IV myocardium versus nonfailing myocardium (p < 0.05). 
entities: mazindol / norepinephrine
ddi: null
>>> match: reveal_VB
-------------
sentence: Concurrent use of alcohol and other CNS depression-producing drugs may increase the CNS depressant effects of methyprylon or these other medications.
entities: alcohol / methyprylon
ddi: effect
>>> match: increase_VB
-------------
sentence: Concurrent use of alcohol and other CNS depression-producing drugs may increase the CNS depressant effects of methyprylon or these other medications.
entities: CNS depression-producing drugs / methyprylon
ddi: effect
>>> match: increase_VB
-------------
sentence: Paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about 50%. 
entities: Paroxetine / endoxifen
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about 50%. 
entities: fluoxetine / endoxifen
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: null
>>> match: inhibit_VB
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / astemizole
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: inhibit_VB
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / cyclosporine
ddi: mechanism
>>> match: alter_VB
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / tacrolimus
ddi: mechanism
>>> match: alter_VB
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / methylprednisolone
ddi: mechanism
>>> match: alter_VB
-------------
sentence: When taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs.
entities: imidazole compounds / coumarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: When taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs.
entities: ketoconazole / coumarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: antacids / piroxicam
ddi: null
>>> match: have_VB
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. 
entities: sulfamethoxazole / anticoagulant
ddi: null
>>> match: prolong_VB
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. 
entities: sulfamethoxazole / warfarin
ddi: effect
>>> match: prolong_VB
-------------
sentence: Sulfamethoxazole may inhibit the hepatic metabolism of phenytoin. 
entities: Sulfamethoxazole / phenytoin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: At a 1.6-g dose, sulfamethoxazole produced a slight but significant increase in the half-life of phenytoin but did not produce a corresponding decrease in the metabolic clearance rate. 
entities: sulfamethoxazole / phenytoin
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations. 
entities: Sulfonamides / methotrexate
ddi: mechanism
>>> match: displace_VB
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: Beta-blockers / insulin
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: clonidine / insulin
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: lithium / insulin
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: alcohol / insulin
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.
entities: indomethacin / captopril
ddi: effect
>>> match: reduce_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / contraceptives
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / antibiotics
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / quinidine
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / theophylline
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / corticosteroids
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / anticoagulants
ddi: effect
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / beta blockers
ddi: effect
>>> match: decrease_VB
-------------
sentence: MAO inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine. 
entities: MAO inhibitors / pseudoephedrine
ddi: effect
>>> match: increase_VB
-------------
sentence: MAO inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine. 
entities: beta adrenergic blockers / pseudoephedrine
ddi: effect
>>> match: increase_VB
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / methyldopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / mecamylamine
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / reserpine
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / veratrum alkaloids
ddi: effect
>>> match: reduce_VB
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: cholestyramine / hydrochlorothiazide
ddi: mechanism
>>> match: bind_VB
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: colestipol / hydrochlorothiazide
ddi: mechanism
>>> match: bind_VB
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: resins / hydrochlorothiazide
ddi: null
>>> match: bind_VB
-------------
sentence: Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.
entities: Diuretic agents / lithium
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.
entities: non-steroidal anti-inflammatory agent / potassium-sparing diuretics
ddi: effect
>>> match: reduce_VB
-------------
sentence: Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.
entities: non-steroidal anti-inflammatory agent / thiazide diuretics
ddi: effect
>>> match: reduce_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: furosemide / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: propranolol / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: captopril / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: nicardipine / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: pravastatin / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: glyburide / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: warfarin / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: phenytoin / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: acetylsalicylic acid / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: tolbutamide / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: metformin / nateglinide
ddi: null
>>> match: show_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / propranolol
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / glyburide
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / nicardipine
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / warfarin
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / acetylsalicylic acid
ddi: null
>>> match: have_VB
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / tolbutamide
ddi: null
>>> match: have_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: nonsteroidal anti-inflammatory agents / Starlix
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: nonsteroidal anti-inflammatory agents / antidiabetic drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: NSAIDs / Starlix
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: NSAIDs / antidiabetic drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: salicylates / Starlix
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: salicylates / antidiabetic drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: monoamine oxidase inhibitors / Starlix
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: monoamine oxidase inhibitors / antidiabetic drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: non-selective beta-adrenergic-blocking agents / Starlix
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: non-selective beta-adrenergic-blocking agents / antidiabetic drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thiazides / Starlix
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thiazides / antidiabetic drugs
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: corticosteroids / Starlix
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: corticosteroids / antidiabetic drugs
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thyroid products / Starlix
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thyroid products / antidiabetic drugs
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: sympathomimetics / Starlix
ddi: effect
>>> match: reduce_VB
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: sympathomimetics / antidiabetic drugs
ddi: effect
>>> match: reduce_VB
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: Naproxen / propranolol
ddi: effect
>>> match: reduce_VB
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: Naproxen / beta-blockers
ddi: effect
>>> match: reduce_VB
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: NSAIDs / propranolol
ddi: effect
>>> match: reduce_VB
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: NSAIDs / beta-blockers
ddi: effect
>>> match: reduce_VB
-------------
sentence: In addition, levetiracetam does not affect the in vitro glucuronidation of valproic acid.
entities: levetiracetam / valproic acid
ddi: null
>>> match: affect_VB
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Keppra / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Antiepileptic Drugs / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: AEDs / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Phenytoin / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Keppra / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Valproate Keppra  (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers.
entities: Valproate / valproate
ddi: null
>>> match: alter_VB
-------------
sentence: Valproate Keppra  (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers.
entities: Keppra / valproate
ddi: null
>>> match: alter_VB
-------------
sentence: Valproate 500 mg twice daily did not modify the rate or extent of levetiracetam absorption or its plasma clearance or urinary excretion.
entities: Valproate / levetiracetam
ddi: null
>>> match: modify_VB
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: levetiracetam / AEDs
ddi: null
>>> match: influence_VB
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: AEDs / levetiracetam
ddi: null
>>> match: influence_VB
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / carbamazepine
ddi: null
>>> match: have_VB
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / valproate
ddi: null
>>> match: have_VB
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / topiramate
ddi: null
>>> match: have_VB
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / lamotrigine
ddi: null
>>> match: have_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Contraceptives / contraceptive
ddi: null
>>> match: influence_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Contraceptives / ethinyl estradiol
ddi: null
>>> match: influence_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Contraceptives / levonorgestrel
ddi: null
>>> match: influence_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Keppra / contraceptive
ddi: null
>>> match: influence_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Keppra / ethinyl estradiol
ddi: null
>>> match: influence_VB
-------------
sentence: Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.
entities: Keppra / levonorgestrel
ddi: null
>>> match: influence_VB
-------------
sentence: Coadministration of this oral contraceptive did not influence the pharmacokinetics of levetiracetam.
entities: contraceptive / levetiracetam
ddi: null
>>> match: influence_VB
-------------
sentence: Digoxin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of digoxin given as a 0.25 mg dose every day.
entities: Digoxin / digoxin
ddi: null
>>> match: influence_VB
-------------
sentence: Digoxin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of digoxin given as a 0.25 mg dose every day.
entities: Keppra / digoxin
ddi: null
>>> match: influence_VB
-------------
sentence: Coadministration of digoxin did not influence the pharmacokinetics of levetiracetam.
entities: digoxin / levetiracetam
ddi: null
>>> match: influence_VB
-------------
sentence: Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.
entities: Warfarin / R warfarin
ddi: null
>>> match: influence_VB
-------------
sentence: Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.
entities: Warfarin / S warfarin
ddi: null
>>> match: influence_VB
-------------
sentence: Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.
entities: Keppra / R warfarin
ddi: null
>>> match: influence_VB
-------------
sentence: Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.
entities: Keppra / S warfarin
ddi: null
>>> match: influence_VB
-------------
sentence: Coadministration of warfarin did not affect the pharmacokinetics of levetiracetam.
entities: warfarin / levetiracetam
ddi: null
>>> match: affect_VB
-------------
sentence: These results suggest that exposure to environmental lead may alter the biological and behavioral responsiveness of an animal to alcohol.
entities: lead / alcohol
ddi: effect
>>> match: alter_VB
-------------
sentence: - Antihypertensives: Bumetanide may potentiate the effect of various antihypertensive drugs, necessitating a reduction in the dosage of these drugs.
entities: Bumetanide / antihypertensive drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: dexamethasone / transferrin
ddi: null
>>> match: affect_VB
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: retinyl acetate / transferrin
ddi: null
>>> match: affect_VB
-------------
sentence: Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF. 
entities: dexamethasone / EGF
ddi: effect
>>> match: enhance_VB
-------------
sentence: Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF. 
entities: retinyl acetate / EGF
ddi: effect
>>> match: enhance_VB
-------------
sentence: Cholestyramine: Cholestyramine may increase the clearance of corticosteroids.
entities: Cholestyramine / corticosteroids
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Ephedrine: Ephedrine may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.
entities: Ephedrine / corticosteroids
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.
entities: Estrogens / corticosteroids
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: barbiturates / corticosteroids
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: phenytoin / corticosteroids
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: carbamazepine / corticosteroids
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: rifampin / corticosteroids
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: In addition, ketoconazole alone can inhibit adrenal corticosteroid synthesis and may cause adrenal insufficiency during corticosteroid withdrawal.
entities: ketoconazole / corticosteroid
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Vaccines: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response.
entities: corticosteroid / live vaccines
ddi: effect
>>> match: exhibit_VB
-------------
sentence: Vaccines: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response.
entities: corticosteroid / inactivated vaccines
ddi: effect
>>> match: exhibit_VB
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / HMG-CoA reductase inhibitors
ddi: null
>>> match: inhibit_VB
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / atorvastatin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / cerivastatin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / lovastatin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / simvastatin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Benazepril, like other ACE inhibitors, has had less than additive effects with beta-adrenergic blockers, presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
entities: Benazepril / beta-adrenergic blockers
ddi: effect
>>> match: have_VB
-------------
sentence: Benazepril, like other ACE inhibitors, has had less than additive effects with beta-adrenergic blockers, presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
entities: ACE inhibitors / beta-adrenergic blockers
ddi: effect
>>> match: have_VB
-------------
sentence: Failure of neomycin to modify ACTH induced hypertension in sheep.
entities: neomycin / ACTH
ddi: null
>>> match: modify_VB
-------------
sentence: Studies in rats have shown that neomycin administration attenuates certain types of adrenocortical steroid dependent hypertension, including ACTH hypertension. 
entities: neomycin / ACTH
ddi: effect
>>> match: attenuate_VB
-------------
sentence: Neomycin has no effect on the blood pressure or metabolic responses to ACTH in sheep.
entities: Neomycin / ACTH
ddi: null
>>> match: have_VB
-------------
sentence: Preliminary data which suggest that dapsone may inhibit the anti-inflammatory activity of Lamprene have not been confirmed.
entities: dapsone / Lamprene
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Fluoxetine and moclobemide increased blood glucose at different times after the glucose overload. 
entities: Fluoxetine / glucose
ddi: null
>>> match: increase_VB
-------------
sentence: Fluoxetine and moclobemide increased blood glucose at different times after the glucose overload. 
entities: moclobemide / glucose
ddi: null
>>> match: increase_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / phenylbutazone
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / warfarin
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / thiazide diuretics
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / propranolol
ddi: mechanism
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / phenylbutazone
ddi: null
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / warfarin
ddi: null
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / thiazide diuretics
ddi: null
>>> match: delay_VB
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / propranolol
ddi: null
>>> match: delay_VB
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / cholinesterase inhibitors
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / succinylcholine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / carbamate insecticides
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Abacavir has no effect on the pharmacokinetic properties of ethanol. 
entities: Abacavir / ethanol
ddi: null
>>> match: have_VB
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: methadone / abacavir
ddi: null
>>> match: have_VB
-------------
sentence: Corticotropin may accentuate the electrolyte loss associated with diuretic therapy.
entities: Corticotropin / diuretic
ddi: effect
>>> match: accentuate_VB
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: isoflurane / NIMBEX
ddi: null
>>> match: have_VB
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: enflurane / NIMBEX
ddi: null
>>> match: have_VB
-------------
sentence: In clinical studies propofol had no effect on the duration of action or dosing requirements for NIMBEX.
entities: propofol / NIMBEX
ddi: null
>>> match: have_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / antibiotics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / aminoglycosides
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / tetracyclines
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / bacitracin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / polymyxins
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / lincomycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / clindamycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / colistin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / sodium colistemethate
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / magnesium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / lithium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / anesthetics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / procainamide
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / quinidine
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / antibiotics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / aminoglycosides
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / tetracyclines
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / bacitracin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / polymyxins
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / lincomycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / clindamycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / colistin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / sodium colistemethate
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / magnesium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / lithium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / anesthetics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / procainamide
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / quinidine
ddi: effect
>>> match: include_VB
-------------
sentence: In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6), coadministration of propafenone did not alter the kinetics of mexiletine in the poor CYP2D6 metabolizer group. 
entities: propafenone / mexiletine
ddi: null
>>> match: alter_VB
-------------
sentence: Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. 
entities: Mexitil / digoxin
ddi: null
>>> match: alter_VB
-------------
sentence: Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. 
entities: Mexitil / magnesium-aluminum hydroxide
ddi: null
>>> match: alter_VB
-------------
sentence: Pretreatment of megakaryocytes with extracellular RR (50 microM) also inhibited InsP(3)-induced responses. 
entities: RR / InsP(3)
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: diminish_VB
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / lisinopril
ddi: effect
>>> match: diminish_VB
-------------
sentence: Administration of diltiazem hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20%.
entities: diltiazem hydrochloride / digoxin
ddi: null
>>> match: increase_VB
-------------
sentence: Administration of diltiazem hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20%.
entities: digoxin / digoxin
ddi: null
>>> match: increase_VB
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / midazolam
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / triazolam
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels.
entities: rifampin / diltiazem
ddi: null
>>> match: lower_VB
-------------
sentence: Coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels.
entities: diltiazem / diltiazem
ddi: null
>>> match: lower_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / norethindrone
ddi: null
>>> match: produce_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / ethinyl estradiol
ddi: null
>>> match: produce_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / norethindrone
ddi: null
>>> match: produce_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / ethinyl estradiol
ddi: null
>>> match: produce_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / norethindrone
ddi: null
>>> match: produce_VB
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / ethinyl estradiol
ddi: null
>>> match: produce_VB
-------------
sentence: Co-administration of bosentan decreased the plasma concentrations of cyclosporine A (a CYP3A4 substrate) by approximately 50%.
entities: bosentan / cyclosporine A
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Co-administration of bosentan decreased the plasma concentrations of glyburide by approximately 40%.
entities: bosentan / glyburide
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Simvastatin and Other Statins: Co-administration of bosentan decreased the plasma concentrations of simvastatin (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.
entities: bosentan / simvastatin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Warfarin: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.
entities: bosentan / S-warfarin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Warfarin: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.
entities: bosentan / R-warfarin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.
entities: bosentan / warfarin
ddi: null
>>> match: show_VB
-------------
sentence: Clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.
entities: warfarin / warfarin
ddi: null
>>> match: show_VB
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / digoxin
ddi: null
>>> match: have_VB
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / nimodipine
ddi: null
>>> match: have_VB
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: losartan / bosentan
ddi: null
>>> match: have_VB
-------------
sentence: Cyclophosphamide treatment, which causes a marked and persistent inhibition of cholinesterase activity, potentiates the effect of succinylcholine chloride.
entities: Cyclophosphamide / succinylcholine chloride
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: antacids / antacid
ddi: null
>>> match: potentiate_VB
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: magnesium / antacid
ddi: null
>>> match: potentiate_VB
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: aluminum / antacid
ddi: null
>>> match: potentiate_VB
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: VIDEX / antacid
ddi: null
>>> match: potentiate_VB
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / phenytoin
ddi: mechanism
>>> match: elevate_VB
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / valproic acid
ddi: null
>>> match: elevate_VB
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: Cholestyramine / T4
ddi: mechanism
>>> match: bind_VB
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: Cholestyramine / T3
ddi: mechanism
>>> match: bind_VB
-------------
sentence: Digitalis: Thyroid preparations may potentiate the toxic effects of digitalis.
entities: Thyroid preparations / digitalis
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Vasopressors: Thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine.
entities: Thyroxine / epinephrine
ddi: effect
>>> match: increase_VB
-------------
sentence: Vasopressors: Thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine.
entities: Thyroxine / norepinephrine
ddi: effect
>>> match: increase_VB
-------------
sentence: Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models.
entities: Dolasetron mesylate / chemotherapeutic agents
ddi: null
>>> match: inhibit_VB
-------------
sentence: Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models.
entities: Dolasetron mesylate / cisplatin
ddi: null
>>> match: inhibit_VB
-------------
sentence: Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models.
entities: Dolasetron mesylate / 5-fluorouracil
ddi: null
>>> match: inhibit_VB
-------------
sentence: Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models.
entities: Dolasetron mesylate / doxorubicin
ddi: null
>>> match: inhibit_VB
-------------
sentence: Dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents (cisplatin, 5-fluorouracil, doxorubicin, cyclophosphamide) in four murine models.
entities: Dolasetron mesylate / cyclophosphamide
ddi: null
>>> match: inhibit_VB
-------------
sentence: Coadministration of fluoxetine significantly decreased cisapride plasma concentrations. 
entities: fluoxetine / cisapride
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / alcohol
ddi: null
>>> match: potentiate_VB
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / alcohol
ddi: null
>>> match: potentiate_VB
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / LEXAPRO
ddi: null
>>> match: potentiate_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: digoxin / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: digoxin / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: Lithium / citalopram
ddi: null
>>> match: have_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: Lithium / lithium
ddi: null
>>> match: have_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: citalopram / citalopram
ddi: null
>>> match: have_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: citalopram / lithium
ddi: null
>>> match: have_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: lithium / citalopram
ddi: null
>>> match: have_VB
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: lithium / lithium
ddi: null
>>> match: have_VB
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: lithium / escitalopram
ddi: effect
>>> match: enhance_VB
-------------
sentence: Racemic citalopram did not alter the mean AUC or Cmax of pimozide.
entities: citalopram / pimozide
ddi: null
>>> match: alter_VB
-------------
sentence: Theophylline - Combined administration of racemic citalopram (40 mg/day for 21 days) and the CYP1A2 substrate theophylline (single dose of 300 mg) did not affect the pharmacokinetics of theophylline.
entities: Theophylline / theophylline
ddi: null
>>> match: affect_VB
-------------
sentence: Theophylline - Combined administration of racemic citalopram (40 mg/day for 21 days) and the CYP1A2 substrate theophylline (single dose of 300 mg) did not affect the pharmacokinetics of theophylline.
entities: citalopram / theophylline
ddi: null
>>> match: affect_VB
-------------
sentence: Theophylline - Combined administration of racemic citalopram (40 mg/day for 21 days) and the CYP1A2 substrate theophylline (single dose of 300 mg) did not affect the pharmacokinetics of theophylline.
entities: theophylline / theophylline
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin - Administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin, a CYP3A4 substrate.
entities: Warfarin / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin - Administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin, a CYP3A4 substrate.
entities: citalopram / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: Carbamazepine / carbamazepine
ddi: null
>>> match: affect_VB
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: citalopram / carbamazepine
ddi: null
>>> match: affect_VB
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: affect_VB
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: carbamazepine / escitalopram
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: Triazolam / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: Triazolam / triazolam
ddi: null
>>> match: affect_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: citalopram / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: citalopram / triazolam
ddi: null
>>> match: affect_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: triazolam / citalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: triazolam / triazolam
ddi: null
>>> match: affect_VB
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: Ketoconazole / ketoconazole
ddi: null
>>> match: decrease_VB
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: citalopram / ketoconazole
ddi: null
>>> match: decrease_VB
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: ketoconazole / ketoconazole
ddi: null
>>> match: decrease_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: Ritonavir / ritonavir
ddi: null
>>> match: affect_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: Ritonavir / escitalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: ritonavir / ritonavir
ddi: null
>>> match: affect_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: ritonavir / escitalopram
ddi: null
>>> match: affect_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: escitalopram / ritonavir
ddi: null
>>> match: affect_VB
-------------
sentence: Ritonavir - Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram.
entities: escitalopram / escitalopram
ddi: null
>>> match: affect_VB
-------------
sentence: However, coadministration of escitalopram (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram.
entities: escitalopram / escitalopram
ddi: null
>>> match: affect_VB
-------------
sentence: However, coadministration of escitalopram (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram.
entities: ritonavir / escitalopram
ddi: null
>>> match: affect_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: vancomycin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: vancomycin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: cefazolin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: cefazolin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ceftazidime / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ceftazidime / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: gentamicin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: gentamicin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: amphotericin / antibiotics
ddi: null
>>> match: demonstrate_VB
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: amphotericin / EXTRANEAL
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Cimetidine: Cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with MONUROL.
entities: Cimetidine / fosfomycin
ddi: null
>>> match: affect_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / contraceptives
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / antibiotics
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / quinidine
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / theophylline
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / corticosteroids
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / anticoagulants
ddi: int
>>> match: decrease_VB
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / beta blockers
ddi: int
>>> match: decrease_VB
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / vardenafil
ddi: null
>>> match: have_VB
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / vardenafil
ddi: null
>>> match: have_VB
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / Vardenafil
ddi: null
>>> match: have_VB
-------------
sentence: Erythromycin (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers.
entities: Erythromycin / vardenafil
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Erythromycin (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers.
entities: Erythromycin / Vardenafil
ddi: null
>>> match: produce_VB
-------------
sentence: Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.
entities: Ketoconazole / vardenafil
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.
entities: Ketoconazole / Vardenafil
ddi: null
>>> match: produce_VB
-------------
sentence: Ritonavir significantly prolonged the half-life of vardenafil to 26 hours.
entities: Ritonavir / vardenafil
ddi: mechanism
>>> match: prolong_VB
-------------
sentence: Nifedipine did not alter the plasma levels of Vardenafil when taken in combination.
entities: Nifedipine / Vardenafil
ddi: null
>>> match: alter_VB
-------------
sentence: Vardenafil (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight).
entities: Vardenafil / alcohol
ddi: null
>>> match: potentiate_VB
-------------
sentence: Aspirin: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).
entities: Aspirin / aspirin
ddi: null
>>> match: potentiate_VB
-------------
sentence: Aspirin: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).
entities: Vardenafil / aspirin
ddi: null
>>> match: potentiate_VB
-------------
sentence: Other interactions: Vardenafil had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).
entities: Vardenafil / glyburide
ddi: null
>>> match: have_VB
-------------
sentence: Other interactions: Vardenafil had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).
entities: Vardenafil / warfarin
ddi: null
>>> match: have_VB
-------------
sentence: Drug Interactions: Women on oral contraceptives have shown a significant increase in plasma vitamin A levels.
entities: contraceptives / vitamin A
ddi: mechanism
>>> match: show_VB
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Steroids / edetate calcium disodium
ddi: effect
>>> match: enhance_VB
-------------
sentence: Concomitant use of barbiturates usually depresses griseofulvin activity and may necessitate raising the dosage.
entities: barbiturates / griseofulvin
ddi: effect
>>> match: depress_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: photosensitizing agents / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: griseofulvin / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: thiazide diuretics / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: sulfonylureas / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: phenothiazines / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: sulfonamides / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: tetracyclines / LEVULAN KERASTICK
ddi: effect
>>> match: increase_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / oxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / desethyloxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / oxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / desethyloxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: aluminum hydroxide / oxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: aluminum hydroxide / desethyloxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: magnesium hydroxide / oxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: magnesium hydroxide / desethyloxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: simethicone / oxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: simethicone / desethyloxybutynin
ddi: null
>>> match: affect_VB
-------------
sentence: Patients on oral antidiabetic agents receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication.
entities: antidiabetic agents / antidiabetic medication
ddi: null
>>> match: require_VB
-------------
sentence: Patients on oral antidiabetic agents receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication.
entities: VELCADE / antidiabetic medication
ddi: null
>>> match: require_VB
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: ciclesonide / des-ciclesonide
ddi: null
>>> match: have_VB
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: ciclesonide / erythromycin
ddi: null
>>> match: have_VB
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: erythromycin / des-ciclesonide
ddi: null
>>> match: have_VB
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: erythromycin / erythromycin
ddi: null
>>> match: have_VB
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ciclesonide / des-ciclesonide
ddi: null
>>> match: increase_VB
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ketoconazole / des-ciclesonide
ddi: null
>>> match: increase_VB
-------------
sentence: Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA. 
entities: Cholestyramine / raloxifene
ddi: mechanism
>>> match: cause_VB
-------------
sentence: In vitro, raloxifene did not affect the binding of warfarin, phenytoin, or tamoxifen. 
entities: raloxifene / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: In vitro, raloxifene did not affect the binding of warfarin, phenytoin, or tamoxifen. 
entities: raloxifene / phenytoin
ddi: null
>>> match: affect_VB
-------------
sentence: In vitro, raloxifene did not affect the binding of warfarin, phenytoin, or tamoxifen. 
entities: raloxifene / tamoxifen
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin: Meclofenamate sodium enhances the effect of warfarin.
entities: Meclofenamate sodium / warfarin
ddi: null
>>> match: enhance_VB
-------------
sentence: Aspirin: Concurrent administration of aspirin may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.
entities: aspirin / meclofenamate sodium
ddi: mechanism
>>> match: lower_VB
-------------
sentence: Meclofenamate sodium does not affect serum salicylate levels.
entities: Meclofenamate sodium / salicylate
ddi: null
>>> match: affect_VB
-------------
sentence: Propoxyphene: The concurrent administration of propoxyphene hydrochloride does not affect the bioavailability of meclofenamate sodium.
entities: propoxyphene hydrochloride / meclofenamate sodium
ddi: null
>>> match: affect_VB
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: effect
>>> match: potentiate_VB
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: null
>>> match: potentiate_VB
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: null
>>> match: potentiate_VB
-------------
sentence: zaleplon did not affect the pharmacokinetics of ethanol.
entities: zaleplon / ethanol
ddi: null
>>> match: affect_VB
-------------
sentence: Additionally, paroxetine did not alter the pharmacokinetics of Sonata, reflecting the absence of a role of CYP2D6 in zaleplon s metabolism.
entities: paroxetine / Sonata
ddi: null
>>> match: alter_VB
-------------
sentence: Additionally, paroxetine did not alter the pharmacokinetics of Sonata, reflecting the absence of a role of CYP2D6 in zaleplon s metabolism.
entities: paroxetine / zaleplon
ddi: null
>>> match: alter_VB
-------------
sentence: Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.
entities: Cimetidine / zaleplon
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Concomitant administration of Sonata (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.
entities: Sonata / zaleplon
ddi: null
>>> match: produce_VB
-------------
sentence: Concomitant administration of Sonata (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.
entities: cimetidine / zaleplon
ddi: null
>>> match: produce_VB
-------------
sentence: Drugs with a Narrow Therapeutic Index Digoxin: Sonata (10 mg) did not affect the pharmacokinetic or pharmacodynamic profile of digoxin (0.375 mg q24h for 8 days).
entities: Sonata / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin: Multiple oral doses of Sonata (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.
entities: Warfarin / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: Warfarin: Multiple oral doses of Sonata (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.
entities: Sonata / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of irbesartan reduced aliskiren Cmax up to 50% after multiple dosing.
entities: irbesartan / aliskiren
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / lovastatin
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / valsartan
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / amlodipine
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / metformin
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / celecoxib
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / atenolol
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / atorvastatin
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / ramipril
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / hydrochlorothiazide
ddi: null
>>> match: affect_VB
-------------
sentence: Fluoxetine does not affect the pharmacokinetics of clonazepam.
entities: Fluoxetine / clonazepam
ddi: null
>>> match: affect_VB
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenytoin / clonazepam
ddi: mechanism
>>> match: induce_VB
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: carbamazepine / clonazepam
ddi: mechanism
>>> match: induce_VB
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenobarbital / clonazepam
ddi: mechanism
>>> match: induce_VB
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / carbamazepine
ddi: mechanism
>>> match: include_VB
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / alcohol
ddi: mechanism
>>> match: include_VB
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / reserpine
ddi: mechanism
>>> match: include_VB
-------------
sentence: - Drugs that may either increase or decrease plasma phenytoin concentrations include: phenobarbital, vaiproic acid, and sodium valproate.
entities: phenytoin / phenobarbital
ddi: mechanism
>>> match: include_VB
-------------
sentence: - Drugs that may either increase or decrease plasma phenytoin concentrations include: phenobarbital, vaiproic acid, and sodium valproate.
entities: phenytoin / sodium valproate
ddi: mechanism
>>> match: include_VB
-------------
sentence: Cimetidine increased the AUC of epirubicin by 50%.
entities: Cimetidine / epirubicin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Nimodipine had no effect on ginsenosides response. 
entities: Nimodipine / ginsenosides
ddi: null
>>> match: have_VB
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: Cholestyramine / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: cholestyramine / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: Colestipol / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: colestipol / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Mineral Oil-Concomitant intake of mineral oil and vitamin K may reduce the absorption of vitamin K.
entities: mineral oil / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Mineral Oil-Concomitant intake of mineral oil and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_VB
-------------
sentence: Orlistat-Orlistat may decrease the absorption of vitamin K.
entities: Orlistat / vitamin K
ddi: null
>>> match: decrease_VB
-------------
sentence: Orlistat-Orlistat may decrease the absorption of vitamin K.
entities: Orlistat / vitamin K
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Warfarin-Vitamin K can antagonize the effect of warfarin
entities: Warfarin / warfarin
ddi: null
>>> match: antagonize_VB
-------------
sentence: Warfarin-Vitamin K can antagonize the effect of warfarin
entities: Vitamin K / warfarin
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: cinacalcet / amitriptyline
ddi: null
>>> match: increase_VB
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: cinacalcet / nortriptyline
ddi: null
>>> match: increase_VB
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: amitriptyline / amitriptyline
ddi: null
>>> match: increase_VB
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: amitriptyline / nortriptyline
ddi: null
>>> match: increase_VB
-------------
sentence: Co-administration of ketoconazole, a strong inhibitor of CYP3A4, increased cinacalcet exposure following a single 90 mg dose of Sensipar by 2.3 fold.
entities: ketoconazole / cinacalcet
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Ephedrine enhances the antinociceptive effect of dexmedetomidine in mice.

entities: Ephedrine / dexmedetomidine
ddi: effect
>>> match: enhance_VB
-------------
sentence: Terfenadine: In a prospective study involving six-healthy-male volunteers, dirithromycin did not affect the metabolism of terfenadine.
entities: dirithromycin / terfenadine
ddi: null
>>> match: affect_VB
-------------
sentence: Paliperidone may antagonize the effect of levodopa and other dopamine agonists. 
entities: Paliperidone / levodopa
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Paliperidone may antagonize the effect of levodopa and other dopamine agonists. 
entities: Paliperidone / dopamine agonists
ddi: effect
>>> match: antagonize_VB
-------------
sentence: CANCIDAS has no effect on the pharmacokinetics of itraconazole, amphotericin B, or the active metabolite of mycophenolate.
entities: CANCIDAS / itraconazole
ddi: null
>>> match: have_VB
-------------
sentence: CANCIDAS has no effect on the pharmacokinetics of itraconazole, amphotericin B, or the active metabolite of mycophenolate.
entities: CANCIDAS / amphotericin B
ddi: null
>>> match: have_VB
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: null
>>> match: reduce_VB
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / CANCIDAS
ddi: null
>>> match: reduce_VB
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: null
>>> match: reduce_VB
-------------
sentence: In two clinical studies, cyclosporine (one 4 mg/kg dose or two 3 mg/kg doses) increased the AUC of caspofungin by approximately 35%.
entities: cyclosporine / caspofungin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: CANCIDAS did not increase the plasma levels of cyclosporine.
entities: CANCIDAS / cyclosporine
ddi: null
>>> match: increase_VB
-------------
sentence: A drug-drug interaction study with rifampin in healthy volunteers has shown a 30% decrease in caspofungin trough concentrations.
entities: rifampin / caspofungin
ddi: mechanism
>>> match: show_VB
-------------
sentence: Patients on rifampin should receive 70 mg of CANCIDAS daily.
entities: rifampin / CANCIDAS
ddi: advise
>>> match: receive_VB
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenobarbital / corticosteroids
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenytoin / corticosteroids
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: rifampin / corticosteroids
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance. 
entities: troleandomycin / corticosteroids
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance. 
entities: ketoconazole / corticosteroids
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Corticosteroids may increase the clearance of chronic high dose aspirin. 
entities: Corticosteroids / aspirin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Dimenhydrinate may decrease emetic response to apomorphine.
entities: Dimenhydrinate / emetic
ddi: null
>>> match: decrease_VB
-------------
sentence: Dimenhydrinate may decrease emetic response to apomorphine.
entities: Dimenhydrinate / apomorphine
ddi: effect
>>> match: decrease_VB
-------------
sentence: MAO inhibitors prolong and intensify the effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_VB
-------------
sentence: Antacids increase the rate of absorption of pseudoephedrine, while kaolin decreases it.
entities: Antacids / pseudoephedrine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Prior administration of succinylcholine can potentiate the neuromuscular blocking effects of nondepolarizing agents. 
entities: succinylcholine / nondepolarizing agents
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / antibiotics
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / aminoglycosides
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / tetracyclines
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / bacitracin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / polymyxins
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / lincomycin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / clindamycin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / colistin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / sodium colistimethate
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / magnesium
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / lithium
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / anesthetics
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / procainamide
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / quinidine
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / antibiotics
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / aminoglycosides
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / tetracyclines
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / bacitracin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / polymyxins
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / lincomycin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / clindamycin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / colistin
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / sodium colistimethate
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / magnesium
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / lithium
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / anesthetics
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / procainamide
ddi: int
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / quinidine
ddi: int
>>> match: include_VB
-------------
sentence: On the other hand, intrathecal naloxone (12-120 micrograms) had only a very weak effect on the tail-flick inhibition induced by intraventricular morphine (40 micrograms). 
entities: naloxone / morphine
ddi: effect
>>> match: have_VB
-------------
sentence: At steady state, VIOXX 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) aspirin, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.
entities: VIOXX / aspirin
ddi: null
>>> match: have_VB
-------------
sentence: Cimetidine: Co-administration with high doses of cimetidine [800 mg twice daily] increased the Cmax of rofecoxib by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.
entities: Cimetidine / rofecoxib
ddi: null
>>> match: increase_VB
-------------
sentence: Cimetidine: Co-administration with high doses of cimetidine [800 mg twice daily] increased the Cmax of rofecoxib by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.
entities: cimetidine / rofecoxib
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Digoxin: Rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose.
entities: Rofecoxib / digoxin
ddi: null
>>> match: alter_VB
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: reduce_VB
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: reduce_VB
-------------
sentence: Ketoconazole: Ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib.
entities: Ketoconazole / rofecoxib
ddi: null
>>> match: have_VB
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: null
>>> match: produce_VB
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: Methotrexate / methotrexate
ddi: null
>>> match: have_VB
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: VIOXX / methotrexate
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone.
entities: Contraceptives / ethinyl estradiol
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone.
entities: Contraceptives / norethindrone
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone.
entities: Rofecoxib / ethinyl estradiol
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone.
entities: Rofecoxib / norethindrone
ddi: null
>>> match: have_VB
-------------
sentence: Prednisone/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.
entities: Rofecoxib / prednisolone
ddi: null
>>> match: have_VB
-------------
sentence: Prednisone/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.
entities: Rofecoxib / prednisone
ddi: null
>>> match: have_VB
-------------
sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.
entities: VIOXX / rofecoxib
ddi: null
>>> match: produce_VB
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: Theophylline / theophylline
ddi: null
>>> match: increase_VB
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: VIOXX / theophylline
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: Quinolones / anticoagulants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: cinoxacin / anticoagulants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: cinoxacin / warfarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: methsuximide / phenytoin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: methsuximide / phenobarbital
ddi: mechanism
>>> match: increase_VB
-------------
sentence: 5-HT3 antagonists: In clinical drug interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron or granisetron.
entities: aprepitant / ondansetron
ddi: null
>>> match: have_VB
-------------
sentence: 5-HT3 antagonists: In clinical drug interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron or granisetron.
entities: aprepitant / granisetron
ddi: null
>>> match: have_VB
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / methylprednisolone
ddi: null
>>> match: achieve_VB
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: achieve_VB
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: Aprepitant / midazolam
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: Aprepitant / midazolam
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.
entities: ELSPAR / methotrexate
ddi: effect
>>> match: diminish_VB
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: cimetidine / mebendazole
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: TCAs decrease the hypotensive effect of guanfacine.
entities: TCAs / guanfacine
ddi: effect
>>> match: decrease_VB
-------------
sentence: This study demonstrated that the potent cytochrome P450 enzyme-inducer phenytoin did indeed have a marked effect on the metabolism of quetiapine, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder. 
entities: phenytoin / quetiapine
ddi: mechanism
>>> match: have_VB
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / atropine
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Ketorolac does not alter digoxin protein binding.
entities: Ketorolac / digoxin
ddi: null
>>> match: alter_VB
-------------
sentence: Furosemide: TORADOL IV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).
entities: TORADOL / diuretic
ddi: null
>>> match: reduce_VB
-------------
sentence: Furosemide: TORADOL IV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).
entities: TORADOL / furosemide
ddi: effect
>>> match: reduce_VB
-------------
sentence: In clinical studies where patients were on chronic theophylline therapy, lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance.
entities: lomefloxacin / theophylline
ddi: null
>>> match: have_VB
-------------
sentence: In clinical studies where patients were on chronic theophylline therapy, lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance.
entities: lomefloxacin / theophylline
ddi: null
>>> match: have_VB
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: Magnesium / lomefloxacin
ddi: null
>>> match: decrease_VB
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: aluminum / lomefloxacin
ddi: null
>>> match: decrease_VB
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: antacids / lomefloxacin
ddi: null
>>> match: decrease_VB
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: lomefloxacin / lomefloxacin
ddi: null
>>> match: decrease_VB
-------------
sentence: Warfarin: Quinolones may enhance the effects of the oral anticoagulant, warfarin, or its derivatives.
entities: Quinolones / anticoagulant
ddi: effect
>>> match: enhance_VB
-------------
sentence: Warfarin: Quinolones may enhance the effects of the oral anticoagulant, warfarin, or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: There is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).
entities: meropenem / valproic acid
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Concomitant administration of an aluminum-containing antacid had no significant effect in the bioavailability of 6MNA.
entities: aluminum / 6MNA
ddi: null
>>> match: have_VB
-------------
sentence: Concomitant administration of an aluminum-containing antacid had no significant effect in the bioavailability of 6MNA.
entities: antacid / 6MNA
ddi: null
>>> match: have_VB
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / diazepam
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / N-desmethyldiazepam
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Rifabutin did not significantly affect amprenavir's pharmacokinetics. 
entities: Rifabutin / amprenavir
ddi: null
>>> match: affect_VB
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: Rifampin / amprenavir
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: amprenavir / rifampin
ddi: null
>>> match: have_VB
-------------
sentence: Rifampin markedly increases the metabolic clearance of amprenavir, and coadministration is contraindicated. 
entities: Rifampin / amprenavir
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Amprenavir significantly decreases clearance of rifabutin and 25-O-desacetylrifabutin, and the combination is poorly tolerated. 
entities: Amprenavir / rifabutin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Amprenavir significantly decreases clearance of rifabutin and 25-O-desacetylrifabutin, and the combination is poorly tolerated. 
entities: Amprenavir / 25-O-desacetylrifabutin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Amphetamines may decrease the hypotensive effect of antihypertensives.
entities: Amphetamines / antihypertensives
ddi: effect
>>> match: decrease_VB
-------------
sentence: Amphetamines may enhance the effects of tricyclic antidepressants.
entities: Amphetamines / tricyclic antidepressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: have_VB
-------------
sentence: Gabapentin had no effect on naproxen pharmacokinetic parameters.
entities: Gabapentin / naproxen
ddi: null
>>> match: have_VB
-------------
sentence: Hydrocodone increases gabapentin AUC values by 14%.
entities: Hydrocodone / gabapentin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Antacid (Maalox ): Maalox reduced the bioavailability of gabapentin (N=16) by about 20%.
entities: Maalox / gabapentin
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: N-methyllevallorphan (5 mg/kg, s.c.) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine. 
entities: N-methyllevallorphan / loperamide
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / divalproex sodium
ddi: null
>>> match: include_VB
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / valproic acid
ddi: null
>>> match: include_VB
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / phenobarbital
ddi: null
>>> match: include_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / steroid medications
ddi: effect
>>> match: affect_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / warfarin
ddi: effect
>>> match: affect_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / anti-infective medicines
ddi: effect
>>> match: affect_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / furosemide
ddi: effect
>>> match: affect_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / theophylline
ddi: effect
>>> match: affect_VB
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / Mephenytoin
ddi: null
>>> match: affect_VB
-------------
sentence: Paroxetine (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine.
entities: Paroxetine / duloxetine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Potential for Duloxetine to Affect Other Drugs: Drugs Metabolized by CYP1A2: In vitro drug interaction studies demonstrate that duloxetine does not induce CYP1A2 activity, and it is unlikely to have a clinically significant effect on the metabolism of CYP1A2 substrates.
entities: Duloxetine / duloxetine
ddi: null
>>> match: affect_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: Duloxetine / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: aluminum / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: magnesium / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: antacids / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: Duloxetine / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: famotidine / duloxetine
ddi: null
>>> match: have_VB
-------------
sentence: It is unknown whether the concomitant administration of proton pump inhibitors affects duloxetine absorption.
entities: proton pump inhibitors / duloxetine
ddi: null
>>> match: affect_VB
-------------
sentence: In a study in normal volunteers, it was found that chronic concurrent administration of 3.6 g of aspirin per day decreases indomethacin blood levels approximately 20%.
entities: aspirin / indomethacin
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: INDOCIN / lithium
ddi: mechanism
>>> match: produce_VB
-------------
sentence: In some patients, the administration of INDOCIN can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing, and thiazide diuretics.
entities: INDOCIN / thiazide diuretics
ddi: effect
>>> match: reduce_VB
-------------
sentence: INDOCIN reduces basal plasma renin activity (PRA), as well as those elevations of PRA induced by furosemide administration, or salt or volume depletion.
entities: INDOCIN / furosemide
ddi: null
>>> match: reduce_VB
-------------
sentence: INDOCIN can reduce the antihypertensive effects of captopril and losartan.
entities: INDOCIN / captopril
ddi: effect
>>> match: reduce_VB
-------------
sentence: INDOCIN can reduce the antihypertensive effects of captopril and losartan.
entities: INDOCIN / losartan
ddi: effect
>>> match: reduce_VB
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: cholestyramine / diuretic
ddi: null
>>> match: prevent_VB
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: colestipol / diuretic
ddi: null
>>> match: prevent_VB
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: thiazide diuretics / diuretic
ddi: null
>>> match: prevent_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBUTEX
ddi: null
>>> match: have_VB
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBOXONE
ddi: null
>>> match: have_VB
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: Intestinal adsorbents / Acarbose
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: charcoal / Acarbose
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: digestive enzyme preparations / Acarbose
ddi: null
>>> match: reduce_VB
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: amylase / Acarbose
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: pancreatin / Acarbose
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / digoxin
ddi: null
>>> match: have_VB
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / nifedipine
ddi: null
>>> match: have_VB
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / propranolol
ddi: null
>>> match: have_VB
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / ranitidine
ddi: null
>>> match: have_VB
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: Concomitant oral administration of ketoconazole (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral budesonide.
entities: ketoconazole / budesonide
ddi: mechanism
>>> match: cause_VB
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_VB
-------------
sentence: Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.
entities: azathioprine / azathioprine
ddi: null
>>> match: have_VB
-------------
sentence: Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.
entities: allopurinol / azathioprine
ddi: null
>>> match: have_VB
-------------
sentence: Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. 
entities: diuretics / aminoglycoside
ddi: effect
>>> match: enhance_VB
-------------
sentence: Probenecid may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged cephalosporin blood levels.
entities: Probenecid / cephalosporins
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Killed virus vaccines / vaccine
ddi: null
>>> match: decrease_VB
-------------
sentence: In a study of 15 male subjects (ages 19 to 35 years) who were extensive metabolizers of the CYP2D6 isoenzyme, daily doses of bupropion given as 150 mg twice daily followed by a single dose of 50 mg desipramine increased the Cmax, AUC, and t1/2 of desipramine by an average of approximately 2-, 5- and 2-fold, respectively.
entities: bupropion / desipramine
ddi: null
>>> match: increase_VB
-------------
sentence: In a study of 15 male subjects (ages 19 to 35 years) who were extensive metabolizers of the CYP2D6 isoenzyme, daily doses of bupropion given as 150 mg twice daily followed by a single dose of 50 mg desipramine increased the Cmax, AUC, and t1/2 of desipramine by an average of approximately 2-, 5- and 2-fold, respectively.
entities: desipramine / desipramine
ddi: null
>>> match: increase_VB
-------------
sentence: In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.
entities: doxapram / muscle relaxant drugs
ddi: effect
>>> match: mask_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / flupenthixol
ddi: effect
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Arecoline
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: affect_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: null
>>> match: cause_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Ethanol / Tricyclic antidepressants
ddi: null
>>> match: cause_VB
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: effect
>>> match: increase_VB
-------------
sentence: Chlorprothixene may increase the plasma-level of concomitantly given lithium.
entities: Chlorprothixene / lithium
ddi: mechanism
>>> match: increase_VB
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: effect
>>> match: amplify_VB
-------------
sentence: Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of R- and S- warfarin.
entities: lenalidomide / R- warfarin
ddi: null
>>> match: have_VB
-------------
sentence: Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of R- and S- warfarin.
entities: lenalidomide / S- warfarin
ddi: null
>>> match: have_VB
-------------
sentence: Co-administration of single 25-mg dose warfarin had no effect on the pharmacokinetics of total lenalidomide.
entities: warfarin / lenalidomide
ddi: null
>>> match: have_VB
-------------
sentence: Cholestyramine, an anionic-binding resin, has a considerable effect in lowering the rate and extent of fluvastatin bioavailability. 
entities: Cholestyramine / fluvastatin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data. 
entities: niacin / fluvastatin
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data. 
entities: propranolol / fluvastatin
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: Dopamine D2 receptor antagonists / levodopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: phenothiazines / levodopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: butyrophenones / levodopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: risperidone / levodopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: isoniazid / levodopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Iron salts may reduce the bioavailability of carbidopa and levodopa.
entities: Iron / carbidopa
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Iron salts may reduce the bioavailability of carbidopa and levodopa.
entities: Iron / levodopa
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying, metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties.
entities: metoclopramide / levodopa
ddi: mechanism
>>> match: increase_VB
-------------
sentence: ondansetron did not increase blood levels of high-dose methotrexate.
entities: ondansetron / methotrexate
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: ketoconazole / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: itraconazole / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: erythromycin / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: clarithromycin / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: ritonavir / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: atazanavir / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: indinavir / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: nefazodone / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: nelfinavir / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: saquinavir / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: telithromycin / dasatinib
ddi: null
>>> match: increase_VB
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: digoxin / anagrelide
ddi: null
>>> match: affect_VB
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: warfarin / anagrelide
ddi: null
>>> match: affect_VB
-------------
sentence: Anagrelide demonstrates some limited inhibitory activity towards CYP1A2 which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g. theophylline.
entities: Anagrelide / theophylline
ddi: mechanism
>>> match: demonstrate_VB
-------------
sentence: A single dose of pravastatin had no clinically important effect on the pharmacokinetics of fenofibric acid.
entities: pravastatin / fenofibric acid
ddi: null
>>> match: have_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / dasatinib
ddi: null
>>> match: inhibit_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / paclitaxel
ddi: null
>>> match: inhibit_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / paclitaxel
ddi: null
>>> match: inhibit_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / dasatinib
ddi: null
>>> match: inhibit_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / paclitaxel
ddi: null
>>> match: inhibit_VB
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / paclitaxel
ddi: null
>>> match: inhibit_VB
-------------
sentence: Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.
entities: dasatinib / paclitaxel
ddi: effect
>>> match: enhance_VB
-------------
sentence: Conversely, the administration of STADOL NS (1 mg butorphanol QID) did not alter the pharmacokinetics of a 300-mg dose of cimetidine.
entities: STADOL NS / cimetidine
ddi: null
>>> match: alter_VB
-------------
sentence: Conversely, the administration of STADOL NS (1 mg butorphanol QID) did not alter the pharmacokinetics of a 300-mg dose of cimetidine.
entities: butorphanol / cimetidine
ddi: null
>>> match: alter_VB
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / fluoxetine
ddi: effect
>>> match: have_VB
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / paroxetine
ddi: effect
>>> match: have_VB
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / amitriptyline
ddi: effect
>>> match: have_VB
-------------
sentence: Extended Release Tablets: Administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers.
entities: nifedipine / digoxin
ddi: null
>>> match: increase_VB
-------------
sentence: Extended Release Tablets: Administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers.
entities: digoxin / digoxin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: However, severe reactions, such as hypotension requiring treatment, dyspnea requiring bronchodilators, angioedema, or generalized urticaria require immediate discontinuation of TAXOL and aggressive symptomatic therapy.
entities: bronchodilators / TAXOL
ddi: null
>>> match: require_VB
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / ethambutol
ddi: null
>>> match: show_VB
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: aluminum hydroxide / ethambutol
ddi: null
>>> match: show_VB
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: antacid / ethambutol
ddi: null
>>> match: show_VB
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: aluminum hydroxide / antacids
ddi: null
>>> match: contain_VB
-------------
sentence: Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.
entities: atorvastatin / antipyrine
ddi: null
>>> match: affect_VB
-------------
sentence: In vitro, buspirone does not displace tightly bound drugs like phenytoin, propranolol, and warfarin from serum proteins.
entities: buspirone / phenytoin
ddi: null
>>> match: displace_VB
-------------
sentence: In vitro, buspirone does not displace tightly bound drugs like phenytoin, propranolol, and warfarin from serum proteins.
entities: buspirone / propranolol
ddi: null
>>> match: displace_VB
-------------
sentence: In vitro, buspirone does not displace tightly bound drugs like phenytoin, propranolol, and warfarin from serum proteins.
entities: buspirone / warfarin
ddi: null
>>> match: displace_VB
-------------
sentence: In vitro, buspirone may displace less firmly bound drugs like digoxin.
entities: buspirone / digoxin
ddi: mechanism
>>> match: displace_VB
-------------
sentence: Similarly, diazepam decreased the antinociceptive effect of metamizol (only in the tail-flick test) and indomethacin. 
entities: diazepam / metamizol
ddi: effect
>>> match: decrease_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / central nervous system depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / barbiturates
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / hypnotics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / narcotic analgesics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / sedatives
ddi: effect
>>> match: enhance_VB
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / tranquillisers
ddi: effect
>>> match: enhance_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / estrogens
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / barbiturates
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / estrogens
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / barbiturates
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: change_VB
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: effect
>>> match: decrease_VB
-------------
sentence: Phenytoin: Isoniazid may increase serum levels of phenytoin.
entities: Isoniazid / phenytoin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: isoniazid / theophylline
ddi: null
>>> match: cause_VB
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: theophylline / theophylline
ddi: null
>>> match: cause_VB
-------------
sentence: Trimethoprim may inhibit the hepatic metabolism of phenytoin. 
entities: Trimethoprim / phenytoin
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. 
entities: Trimethoprim / phenytoin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: permit_VB
-------------
sentence: This may occur because diflunisal competitively displaces coumarins from protein binding sites.
entities: diflunisal / coumarins
ddi: mechanism
>>> match: displace_VB
-------------
sentence: Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.
entities: Diflunisal / hydrochlorothiazide
ddi: effect
>>> match: decrease_VB
-------------
sentence: Furosemide: In normal volunteers, the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide.
entities: furosemide / furosemide
ddi: null
>>> match: have_VB
-------------
sentence: Diflunisal decreased the hyperuricemic effect of furosemide.
entities: Diflunisal / furosemide
ddi: effect
>>> match: decrease_VB
-------------
sentence: Antacids: Concomitant administration of antacids may reduce plasma levels of diflunisal.
entities: antacids / diflunisal
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Acetaminophen had no effect on plasma levels of diflunisal.
entities: Acetaminophen / diflunisal
ddi: null
>>> match: have_VB
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: diflunisal / naproxen
ddi: null
>>> match: have_VB
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: naproxen / naproxen
ddi: null
>>> match: have_VB
-------------
sentence: Naproxen had no effect on plasma levels of diflunisal.
entities: Naproxen / diflunisal
ddi: null
>>> match: have_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: Acetaminophen / acetaminophen
ddi: null
>>> match: decrease_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: Acetaminophen / methotrexate
ddi: null
>>> match: decrease_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: methotrexate / acetaminophen
ddi: null
>>> match: decrease_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: decrease_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: L-methionine / acetaminophen
ddi: effect
>>> match: decrease_VB
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: L-methionine / methotrexate
ddi: effect
>>> match: decrease_VB
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / terfenadine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / astemizole
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / cisapride
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / cyclosporine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / tricyclic antidepressants
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: n-dodecyl gallate showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude tannic acid. 
entities: n-dodecyl gallate / tannic acid
ddi: null
>>> match: show_VB
-------------
sentence: Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.
entities: Phenothiazines / epinephrine
ddi: effect
>>> match: reduce_VB
-------------
sentence: Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.
entities: butyrophenones / epinephrine
ddi: effect
>>> match: reduce_VB
-------------
sentence: MAO-A inhibitors reduce sumatriptan clearance, significantly increasing systemic exposure. 
entities: MAO-A inhibitors / sumatriptan
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: hexobarbital / chlorpromazine
ddi: null
>>> match: increase_VB
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: ethyl alcohol / chlorpromazine
ddi: null
>>> match: increase_VB
-------------
sentence: In bioavailability studies with normal subjects, the concurrent administration of antacids at therapeutic levels did not significantly influence the bioavailability of TRANXENE tablets.
entities: antacids / TRANXENE
ddi: null
>>> match: influence_VB
-------------
sentence: Interactions for Vitamin B3 (Niacin): Antihypertensive Therapy: Nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension.
entities: Nicotinic acid / ganglionic blocking agents
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Aspirin: Concomitant aspirin may decrease the metabolic clearance of nicotinic acid.
entities: aspirin / nicotinic acid
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: A daily dose of 2 mg of coumaphos/kg of body weight for 6 days did not affect the plasma enzymes or the antiprothrombinemic effect of bishydroxy-coumarin in wethers. 
entities: coumaphos / bishydroxy-coumarin
ddi: null
>>> match: affect_VB
-------------
sentence: Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine HCl should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.
entities: MAO inhibitors / dopamine HCl
ddi: null
>>> match: receive_VB
-------------
sentence: Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine HCl should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.
entities: dopamine HCl / dopamine HCl
ddi: null
>>> match: receive_VB
-------------
sentence: The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.
entities: alcohol / alcohol
ddi: null
>>> match: affect_VB
-------------
sentence: The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.
entities: alcohol / acamprosate
ddi: null
>>> match: affect_VB
-------------
sentence: The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.
entities: Acamprosate / alcohol
ddi: null
>>> match: affect_VB
-------------
sentence: The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.
entities: Acamprosate / acamprosate
ddi: null
>>> match: affect_VB
-------------
sentence: Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.
entities: disulfiram / acamprosate
ddi: null
>>> match: affect_VB
-------------
sentence: Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.
entities: diazepam / acamprosate
ddi: null
>>> match: affect_VB
-------------
sentence: Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.
entities: naltrexone / acamprosate
ddi: null
>>> match: produce_VB
-------------
sentence: Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.
entities: Acamprosate / acamprosate
ddi: null
>>> match: produce_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Stavudine / stavudine
ddi: null
>>> match: antagonize_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Stavudine / zidovudine
ddi: null
>>> match: antagonize_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Zidovudine / stavudine
ddi: null
>>> match: antagonize_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Zidovudine / zidovudine
ddi: null
>>> match: antagonize_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Ribavirin / stavudine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Ribavirin / zidovudine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: PEGASYS contains benzyl alcohol.
entities: PEGASYS / benzyl alcohol
ddi: null
>>> match: contain_VB
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_VB
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: Contraceptives / ethinyl estradiol
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: Contraceptives / contraceptives
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: cefditoren pivoxil / ethinyl estradiol
ddi: null
>>> match: have_VB
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: cefditoren pivoxil / contraceptives
ddi: null
>>> match: have_VB
-------------
sentence: H2-Receptor Antagonists: Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.
entities: H2-Receptor Antagonists / cefditoren pivoxil
ddi: null
>>> match: reduce_VB
-------------
sentence: H2-Receptor Antagonists: Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.
entities: famotidine / cefditoren pivoxil
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: BREVIBLOC / warfarin
ddi: null
>>> match: alter_VB
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: warfarin / warfarin
ddi: null
>>> match: alter_VB
-------------
sentence: Digoxin did not affect BREVIBLOC pharmacokinetics.
entities: Digoxin / BREVIBLOC
ddi: null
>>> match: affect_VB
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_VB
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: cimetidine / antidepressants
ddi: null
>>> match: decrease_VB
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: tricyclic antidepressants / antidepressants
ddi: null
>>> match: decrease_VB
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: cimetidine / antidepressants
ddi: null
>>> match: decrease_VB
-------------
sentence: Repeating the study with 6 healthy male volunteers in the absence of glibenclamide did not detect an effect of acitretin on glucose tolerance.
entities: glibenclamide / acitretin
ddi: null
>>> match: detect_VB
-------------
sentence: A single dose of liquid antacid did not affect the C max or AUC of ceftibuten;
entities: antacid / ceftibuten
ddi: null
>>> match: affect_VB
-------------
sentence: however, 150 mg of ranitidine q12h for 3 days increased the ceftibuten C max by 23% and ceftibuten AUC by 16%.
entities: ranitidine / ceftibuten
ddi: mechanism
>>> match: increase_VB
-------------
sentence: The results of assays using red cells from healthy subjects to determine whether ceftibuten would cause direct Coombs reactions in vitro showed no positive reaction at ceftibuten concentrations as high as 40  g/mL.
entities: ceftibuten / ceftibuten
ddi: null
>>> match: show_VB
-------------
sentence: Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.
entities: ketoconazole / exemestane
ddi: null
>>> match: have_VB
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: rifampicin / exemestane
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: phenytoin / exemestane
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: carbamazepine / exemestane
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: phenobarbital / exemestane
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Since entecavir is primarily eliminated by the kidneys, coadministration of BARACLUDE with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug.
entities: BARACLUDE / entecavir
ddi: null
>>> match: increase_VB
-------------
sentence: ZINECARD does not influence the pharmacokinetics of doxorubicin.
entities: ZINECARD / doxorubicin
ddi: null
>>> match: influence_VB
-------------
sentence: Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.
entities: fluoxetine / alprazolam
ddi: null
>>> match: increase_VB
-------------
sentence: Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.
entities: alprazolam / alprazolam
ddi: null
>>> match: increase_VB
-------------
sentence: Coadministration of propoxyphene decreased the maximum plasma concentration of alprazolam by 6%, decreased clearance by 38%, and increased half-life by 58%.
entities: propoxyphene / alprazolam
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Coadministration of oral contraceptives increased the maximum plasma concentration of alprazolam by 18%, decreased clearance by 22%, and increased half-life by 29%.
entities: contraceptives / alprazolam
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / alprazolam
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / diltiazem
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / isoniazid
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / macrolide antibiotics
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / erythromycin
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / clarithromycin
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / alprazolam
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / diltiazem
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / isoniazid
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / macrolide antibiotics
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / erythromycin
ddi: null
>>> match: suggest_VB
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / clarithromycin
ddi: null
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / alprazolam
ddi: null
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / sertraline
ddi: null
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / paroxetine
ddi: null
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / ergotamine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / cyclosporine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / amiodarone
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / nicardipine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / nifedipine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / ergotamine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / cyclosporine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / amiodarone
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / nicardipine
ddi: int
>>> match: suggest_VB
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / nifedipine
ddi: int
>>> match: suggest_VB
-------------
sentence: Concomitant use of calcium supplements and L-lysine may increase calcium absorption
entities: calcium / calcium
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant use of calcium supplements and L-lysine may increase calcium absorption
entities: L-lysine / calcium
ddi: null
>>> match: increase_VB
-------------
sentence: Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.
entities: Fexofenadine / erythromycin
ddi: null
>>> match: have_VB
-------------
sentence: Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.
entities: Fexofenadine / ketoconazole
ddi: null
>>> match: have_VB
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: erythromycin / fexofenadine
ddi: mechanism
>>> match: enhance_VB
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: Antacids / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: fexofenadine hydrochloride / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: aluminum / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: magnesium / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: antacid / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: Maalox / fexofenadine
ddi: null
>>> match: decrease_VB
-------------
sentence: Methadone: Coadministration of amprenavir and methadone can decrease plasma levels of methadone.
entities: amprenavir / methadone
ddi: null
>>> match: decrease_VB
-------------
sentence: Methadone: Coadministration of amprenavir and methadone can decrease plasma levels of methadone.
entities: methadone / methadone
ddi: null
>>> match: decrease_VB
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: antagonize_VB
-------------
sentence: Physostigmine pretreatment augmented the depressant effect of alcohol on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3. 
entities: Physostigmine / alcohol
ddi: effect
>>> match: augment_VB
-------------
sentence: Administration of dantrolene may potentiate vecuronium-induced neuromuscular block.
entities: dantrolene / vecuronium
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: rifampin / bexarotene
ddi: mechanism
>>> match: cause_VB
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: phenytoin / bexarotene
ddi: mechanism
>>> match: cause_VB
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: phenobarbital / bexarotene
ddi: mechanism
>>> match: cause_VB
-------------
sentence: Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).
entities: lapatinib / capecitabine
ddi: null
>>> match: alter_VB
-------------
sentence: Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).
entities: capecitabine / capecitabine
ddi: null
>>> match: alter_VB
-------------
sentence: Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA.
entities: rifampin / ZEBETA
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA.
entities: rifampin / ZEBETA
ddi: null
>>> match: increase_VB
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / anticoagulants of the coumarin type
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / narcotic analgesics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / anesthetics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / tranquilizers
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / chlordiazepoxide
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / sedative-hypnotics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / narcotic analgesics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / anesthetics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / tranquilizers
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / chlordiazepoxide
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / sedative-hypnotics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / narcotic analgesics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / anesthetics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / tranquilizers
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / chlordiazepoxide
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / sedative-hypnotics
ddi: effect
>>> match: enhance_VB
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Anticholinergics antagonize the effects of antiglaucoma agents.
entities: Anticholinergics / antiglaucoma agents
ddi: null
>>> match: antagonize_VB
-------------
sentence: Anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin;
entities: Anticholinergic agents / digoxin
ddi: mechanism
>>> match: affect_VB
-------------
sentence: Anticholinergic drugs may antagonize the effects of the drugs that alter gastrointestinal motility, such as metoclopramide.
entities: Anticholinergic drugs / metoclopramide
ddi: mechanism
>>> match: antagonize_VB
-------------
sentence: Potential drug interactions for doxylamine include, increased sedation if doxylamine is combined with other CNS depressant drugs.
entities: doxylamine / doxylamine
ddi: null
>>> match: include_VB
-------------
sentence: Potential drug interactions for doxylamine include, increased sedation if doxylamine is combined with other CNS depressant drugs.
entities: doxylamine / CNS depressant drugs
ddi: null
>>> match: include_VB
-------------
sentence: Antihistamines may partially counteract the anticoagulation effects of heparin or warfarin.
entities: Antihistamines / heparin
ddi: effect
>>> match: counteract_VB
-------------
sentence: Antihistamines may partially counteract the anticoagulation effects of heparin or warfarin.
entities: Antihistamines / warfarin
ddi: effect
>>> match: counteract_VB
-------------
sentence: Doxylamine may enhance the effects of epinephrine.
entities: Doxylamine / epinephrine
ddi: effect
>>> match: enhance_VB
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: oxcarbazepine / dihydropyridine calcium antagonists
ddi: null
>>> match: induce_VB
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: oxcarbazepine / contraceptives
ddi: null
>>> match: induce_VB
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: MHD / dihydropyridine calcium antagonists
ddi: null
>>> match: induce_VB
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: MHD / contraceptives
ddi: null
>>> match: induce_VB
-------------
sentence: Verapamil produced a decrease of 20% [90% CI: 18-27] of the plasma levels of MHD.
entities: Verapamil / MHD
ddi: null
>>> match: produce_VB
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: Cimetidine / MHD
ddi: null
>>> match: have_VB
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: erythromycin / MHD
ddi: null
>>> match: have_VB
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: dextropropoxyphene / MHD
ddi: null
>>> match: have_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: antibiotics / folic acid
ddi: null
>>> match: invalidate_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: antibiotics / vitamin B12
ddi: null
>>> match: invalidate_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: methotrexate / folic acid
ddi: null
>>> match: invalidate_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: methotrexate / vitamin B12
ddi: null
>>> match: invalidate_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: pyrimethamine / folic acid
ddi: null
>>> match: invalidate_VB
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: pyrimethamine / vitamin B12
ddi: null
>>> match: invalidate_VB
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: Colchicine / vitamin B12
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: para-aminosalicylic acid / vitamin B12
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: alcohol / vitamin B12
ddi: mechanism
>>> match: produce_VB
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: INSPRA / eplerenone
ddi: null
>>> match: show_VB
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: INSPRA / eplerenone
ddi: null
>>> match: show_VB
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: ketoconazole / eplerenone
ddi: null
>>> match: show_VB
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: ketoconazole / eplerenone
ddi: null
>>> match: show_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ACE inhibitors
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / angiotensin II receptor antagonists
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ACEI
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ARB
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ACE inhibitors
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / angiotensin II receptor antagonists
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ACEI
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ARB
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ACE inhibitors
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / angiotensin II receptor antagonists
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ACEI
ddi: null
>>> match: receive_VB
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ARB
ddi: null
>>> match: receive_VB
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: methylxanthines / adrenergic agonists
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: aminophylline / adrenergic agonists
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: theophylline / adrenergic agonists
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: steroids / adrenergic agonists
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: diuretics / adrenergic agonists
ddi: effect
>>> match: potentiate_VB
-------------
sentence: In two combined 12-week placebo controlled trials that included BROVANA doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_VB
-------------
sentence: In a 12-month controlled trial that included a 50 mcg once daily BROVANA dose, 30 of the 528 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_VB
-------------
sentence: In a 12-month controlled trial that included a 50 mcg once daily BROVANA dose, 30 of the 528 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_VB
-------------
sentence: Beta-blockers not only block the therapeutic effects of beta-agonists, but may produce severe bronchospasm in COPD patients.
entities: Beta-blockers / beta-agonists
ddi: effect
>>> match: block_VB
-------------
sentence: H1 and H2 Blockers - Although not reported, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers.
entities: L-histidine / H1 blockers
ddi: effect
>>> match: decrease_VB
-------------
sentence: H1 and H2 Blockers - Although not reported, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers.
entities: L-histidine / H2 blockers
ddi: effect
>>> match: decrease_VB
-------------
sentence: Alcohol: Concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects. 
entities: alcohol / mirtazapine
ddi: mechanism
>>> match: have_VB
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: diazepam / mirtazapine
ddi: mechanism
>>> match: have_VB
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / warfarin
ddi: null
>>> match: influence_VB
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / acetylsalicylic acid
ddi: null
>>> match: influence_VB
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / piroxicam
ddi: null
>>> match: influence_VB
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / digoxin
ddi: null
>>> match: influence_VB
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / digoxin
ddi: null
>>> match: influence_VB
-------------
sentence: Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.
entities: linezolid / adrenergic
ddi: int
>>> match: have_VB
-------------
sentence: Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.
entities: linezolid / serotonergic agents
ddi: int
>>> match: have_VB
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / sympathomimetic agents
ddi: effect
>>> match: experience_VB
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / vasopressor
ddi: effect
>>> match: experience_VB
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / dopaminergic agents
ddi: effect
>>> match: experience_VB
-------------
sentence: Methysergide may reverse the analgesic activity of narcotic analgesics. 
entities: Methysergide / narcotic analgesics
ddi: effect
>>> match: reverse_VB
-------------
sentence: Coadministration of phenytoin with 40 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.
entities: phenytoin / nisoldipine
ddi: null
>>> match: lower_VB
-------------
sentence: Coadministration of phenytoin with 40 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.
entities: SULAR / nisoldipine
ddi: null
>>> match: lower_VB
-------------
sentence: Propranolol attenuated the heart rate increase following administration of immediate release nisoldipine.
entities: Propranolol / nisoldipine
ddi: effect
>>> match: attenuate_VB
-------------
sentence: Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but not the peak concentration.
entities: Quinidine / nisoldipine
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: The immediate release, but not the coat-core formulation of nisoldipine increased plasma quinidine concentrations by about 20%.
entities: nisoldipine / quinidine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.
entities: alcohol / bromocriptine mesylate
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Physiological changes resulting from smoking cessation, with or without nicotine replacement, may alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and theophylline.
entities: nicotine / tricyclic antidepressants
ddi: null
>>> match: alter_VB
-------------
sentence: Physiological changes resulting from smoking cessation, with or without nicotine replacement, may alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and theophylline.
entities: nicotine / theophylline
ddi: null
>>> match: alter_VB
-------------
sentence: Coadministration of digoxin did not have effects on either the safety or efficacy of ibutilide in the clinical trials.
entities: digoxin / ibutilide
ddi: null
>>> match: have_VB
-------------
sentence: Calcium channel blocking agents: Coadministration of calcium channel blockers did not have any effect on either the safety or efficacy of ibutilide in the clinical trials.
entities: calcium channel blockers / ibutilide
ddi: null
>>> match: have_VB
-------------
sentence: Beta-adrenergic blocking agents: Coadministration of beta-adrenergic blocking agents did not have any effect on either the safety or efficacy of ibutilide in the clinical trials.
entities: beta-adrenergic blocking agents / ibutilide
ddi: null
>>> match: have_VB
-------------
sentence: The concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.
entities: allopurinol / ampicillin
ddi: null
>>> match: increase_VB
-------------
sentence: The concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.
entities: ampicillin / ampicillin
ddi: null
>>> match: increase_VB
-------------
sentence: In common with other broad-spectrum antibiotics, AUGMENTIN XR may reduce the efficacy of oral contraceptives
entities: AUGMENTIN XR / contraceptives
ddi: effect
>>> match: reduce_VB
-------------
sentence: Azithromycin did not affect the prothrombin time response to a single dose of warfarin.
entities: Azithromycin / warfarin
ddi: null
>>> match: affect_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / atorvastatin
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / carbamazepine
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / cetirizine
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / didanosine
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / efavirenz
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / fluconazole
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / indinavir
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / midazolam
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / rifabutin
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / sildenafil
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / theophylline
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / triazolam
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / trimethoprim
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / sulfamethoxazole
ddi: mechanism
>>> match: have_VB
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / zidovudine
ddi: mechanism
>>> match: have_VB
-------------
sentence: Co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin.
entities: efavirenz / azithromycin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin.
entities: fluconazole / azithromycin
ddi: mechanism
>>> match: have_VB
-------------
sentence: Itraconazole decreases busulfan clearance by up to 25%, and may produce AUCs   1500  M min in some patients.
entities: Itraconazole / busulfan
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Phenytoin increases the clearance of busulfan by 15% or more, possibly due to the induction of glutathione-S-transferase.
entities: Phenytoin / busulfan
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: probenecid / cefdinir
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Concomitantly administered iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics.
entities: iron / cefdinir
ddi: null
>>> match: have_VB
-------------
sentence: Concomitantly administered iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics.
entities: iron / cefdinir
ddi: null
>>> match: have_VB
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: anti-malarial drugs / carbamazepine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: chloroquine / carbamazepine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: mefloquine / carbamazepine
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: Allopurinol / mercaptopurine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: Allopurinol / azathioprine
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: allopurinol / mercaptopurine
ddi: advise
>>> match: require_VB
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: allopurinol / azathioprine
ddi: advise
>>> match: require_VB
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / anticoagulant
ddi: null
>>> match: prolong_VB
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / dicumarol
ddi: mechanism
>>> match: prolong_VB
-------------
sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
entities: allopurinol / cyclophosphamide
ddi: null
>>> match: increase_VB
-------------
sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
entities: allopurinol / doxorubicin
ddi: null
>>> match: increase_VB
-------------
sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
entities: allopurinol / bleomycin
ddi: null
>>> match: increase_VB
-------------
sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
entities: allopurinol / procarbazine
ddi: null
>>> match: increase_VB
-------------
sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
entities: allopurinol / mechlorethamine
ddi: null
>>> match: increase_VB
-------------
sentence: Fluoxetine and its active metabolite, norfluoxe-tine, have long half-lives (4 to 16 days for norfluoxetine), that may affect strategies during conversion from one drug to the other.
entities: Fluoxetine / norfluoxetine
ddi: null
>>> match: have_VB
-------------
sentence: Exposure of the muscle to ouabain (10(-5) M) markedly increased the PTX-induced release. 
entities: ouabain / PTX
ddi: effect
>>> match: increase_VB
-------------
sentence: Phenytoin/Phenobarbital: The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D, but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism.
entities: phenytoin / vitamin D
ddi: null
>>> match: affect_VB
-------------
sentence: Phenytoin/Phenobarbital: The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D, but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism.
entities: phenobarbital / vitamin D
ddi: null
>>> match: affect_VB
-------------
sentence: Ketoconazole: Ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin D.
entities: Ketoconazole / vitamin D
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Monoamine oxidase (MAO) inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: Monoamine oxidase (MAO) inhibitors / antihistamines
ddi: effect
>>> match: prolong_VB
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / tricyclic antidepressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / barbiturates
ddi: effect
>>> match: enhance_VB
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_VB
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / reserpine
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / veratrum alkaloids
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / methyldopa
ddi: effect
>>> match: reduce_VB
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / mecamylamine
ddi: effect
>>> match: reduce_VB
-------------
sentence: It was concluded that, although gentamycin did augment the neuromuscular blockade of atracurium, the effect was minimal.
entities: gentamycin / atracurium
ddi: effect
>>> match: augment_VB
-------------
sentence: Phenytoin/Phenobarbital: The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D, but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism.
entities: phenytoin / vitamin D
ddi: null
>>> match: affect_VB
-------------
sentence: Phenytoin/Phenobarbital: The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D, but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism.
entities: phenobarbital / vitamin D
ddi: null
>>> match: affect_VB
-------------
sentence: Ketoconazole: Ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin D.
entities: Ketoconazole / vitamin D
ddi: mechanism
>>> match: inhibit_VB
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / simvastatin
ddi: null
>>> match: increase_VB
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / simvastatin
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / morphine
ddi: null
>>> match: decrease_VB
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / cocaine
ddi: null
>>> match: decrease_VB
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / ethanol
ddi: null
>>> match: decrease_VB
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / nicotine
ddi: null
>>> match: decrease_VB
-------------
sentence: Both ibogaine and 18-MC ameliorate opioid withdrawal signs. 
entities: ibogaine / opioid
ddi: null
>>> match: ameliorate_VB
-------------
sentence: Both ibogaine and 18-MC ameliorate opioid withdrawal signs. 
entities: 18-MC / opioid
ddi: null
>>> match: ameliorate_VB
-------------
sentence: only ibogaine enhances cocaine-induced increases in accumbal dopamine. 
entities: ibogaine / cocaine
ddi: effect
>>> match: enhance_VB
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: 18-MC / ibogaine
ddi: null
>>> match: have_VB
-------------
sentence: Lithium: Diclofenac decreases lithium renal clearance and increases lithium plasma levels.
entities: Diclofenac / lithium
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: A direct causal relationship has not been established, but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents.
entities: diclofenac / insulin
ddi: effect
>>> match: alter_VB
-------------
sentence: A direct causal relationship has not been established, but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents.
entities: diclofenac / hypoglycemic agents
ddi: effect
>>> match: alter_VB
-------------
sentence: Diuretics: Diclofenac and other NSAIDs can inhibit the activity of diuretics.
entities: Diclofenac / diuretics
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Diuretics: Diclofenac and other NSAIDs can inhibit the activity of diuretics.
entities: NSAIDs / diuretics
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: azathioprine / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: gold / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: chloroquine / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: D-penicillamine / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: prednisolone / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: doxycycline / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: digitoxin / diclofenac
ddi: null
>>> match: affect_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: Benzylpenicillin / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: ampicillin / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: oxacillin / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: chlortetracycline / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: doxycycline / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: cephalothin / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: erythromycin / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: sulfamethoxazole / diclofenac
ddi: null
>>> match: have_VB
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / contraceptive agents
ddi: null
>>> match: have_VB
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / ethinyl estradiol
ddi: null
>>> match: have_VB
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / levonorgestrel
ddi: null
>>> match: have_VB
-------------
sentence: Cholestyramine: Concomitant cholestyramine administration decreased the mean AUC of total ezetimibe approximately 55%. 
entities: cholestyramine / ezetimibe
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Fenofibrate: In a pharmacokinetic study, concomitant fenofibrate administration increased total ezetimibe concentrations approximately 1.5-fold. 
entities: fenofibrate / ezetimibe
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Gemfibrozil: In a pharmacokinetic study, concomitant gemfibrozil administration increased total ezetimibe concentrations approximately 1.7-fold. 
entities: gemfibrozil / ezetimibe
ddi: null
>>> match: increase_VB
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / sucralfate
ddi: null
>>> match: fluoroquinolone_VB
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / gelusil
ddi: null
>>> match: fluoroquinolone_VB
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / erythromycin
ddi: null
>>> match: fluoroquinolone_VB
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / multi minerals
ddi: null
>>> match: fluoroquinolone_VB
-------------
sentence: Zidovudine competitively inhibits the intracellular phosphorylation of stavudine. 
entities: Zidovudine / stavudine
ddi: effect
>>> match: inhibit_VB
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: Quinolones / anticoagulant
ddi: null
>>> match: enhance_VB
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: nalidixic acid / anticoagulant
ddi: null
>>> match: enhance_VB
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: nalidixic acid / warfarin
ddi: effect
>>> match: enhance_VB
-------------
sentence: apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning.
entities: diphenidol / emetic
ddi: null
>>> match: decrease_VB
-------------
sentence: apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning.
entities: diphenidol / apomorphine
ddi: effect
>>> match: decrease_VB
-------------
sentence: HEMABATE may augment the activity of other oxytocic agents.
entities: HEMABATE / oxytocic agents
ddi: effect
>>> match: augment_VB
-------------
sentence: Cytadren accelerates the metabolism of dexamethasone;
entities: Cytadren / dexamethasone
ddi: mechanism
>>> match: accelerate_VB
-------------
sentence: Aminoglutethimide diminishes the effect of coumarin and warfarin.
entities: Aminoglutethimide / coumarin
ddi: effect
>>> match: diminish_VB
-------------
sentence: Aminoglutethimide diminishes the effect of coumarin and warfarin.
entities: Aminoglutethimide / warfarin
ddi: effect
>>> match: diminish_VB
-------------
sentence: ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia.

entities: ADL 8-2698 / morphine
ddi: effect
>>> match: prevent_VB
-------------
sentence: We conclude that ADL 8-2698 prevents morphine-induced increases in gastrointestinal transit time by means of selective peripheral opioid anitagonism without affecting central opioid analgesia.
entities: ADL 8-2698 / morphine
ddi: effect
>>> match: prevent_VB
-------------
sentence: Milk, milk products, and calcium-rich foods or drugs may impair the absorption of EMCYT.
entities: calcium / EMCYT
ddi: mechanism
>>> match: impair_VB
-------------
sentence: DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin.
entities: DIAMOX / phenytoin
ddi: mechanism
>>> match: modify_VB
-------------
sentence: By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect.
entities: DIAMOX / primidone
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Acetazolamide may increase the effects of other folic acid antagonists.
entities: Acetazolamide / folic acid antagonists
ddi: effect
>>> match: increase_VB
-------------
sentence: Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect.
entities: Acetazolamide / amphetamine
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Acetazolamide reduces urinary excretion of quinidine and may enhance its effect.
entities: Acetazolamide / quinidine
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Acetazolamide may prevent the urinary antiseptic effect of methenamine.
entities: Acetazolamide / methenamine
ddi: effect
>>> match: prevent_VB
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: null
>>> match: increase_VB
-------------
sentence: Acetazolamide may elevate cyclosporine levels.
entities: Acetazolamide / cyclosporine
ddi: mechanism
>>> match: elevate_VB
-------------
sentence: Cholinesterase Inhibitors: Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis.
entities: Dipyridamole / cholinesterase inhibitors
ddi: effect
>>> match: counteract_VB
-------------
sentence: Digoxin: Some calcium blockers may increase the concentration of digitalis preparations in the blood.
entities: calcium blockers / digitalis preparations
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Nicardipine HCl usually does not alter the plasma levels of digoxin, however, serum digoxin levels should be evaluated after concomitant therapy with nicardipine HCl is initiated.
entities: Nicardipine HCl / digoxin
ddi: null
>>> match: alter_VB
-------------
sentence: Maalox * Coadministration of Maalox TC had no effect on nicardipine HCl absorption.
entities: Maalox / nicardipine HCl
ddi: null
>>> match: have_VB
-------------
sentence: Maalox * Coadministration of Maalox TC had no effect on nicardipine HCl absorption.
entities: Maalox TC / nicardipine HCl
ddi: null
>>> match: have_VB
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / alcohol
ddi: effect
>>> match: have_VB
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / CNS depressants
ddi: effect
>>> match: have_VB
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_VB
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: antagonize_VB
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: antagonize_VB
-------------
sentence: In pigeons, naloxone did not systematically alter the effects of (-)-NANM, (+)-NANM or PCP. 
entities: naloxone / (-)-NANM
ddi: null
>>> match: alter_VB
-------------
sentence: In pigeons, naloxone did not systematically alter the effects of (-)-NANM, (+)-NANM or PCP. 
entities: naloxone / PCP
ddi: null
>>> match: alter_VB
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: Haloperidol / (+)-NANM
ddi: effect
>>> match: reduce_VB
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: Haloperidol / PCP
ddi: effect
>>> match: reduce_VB
-------------
sentence: Imipramine hydrochloride may potentiate the effects of CNS depressant drugs.
entities: Imipramine hydrochloride / CNS depressant drugs
ddi: effect
>>> match: potentiate_VB
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_VB
-------------
sentence: Prior administration of succinylcholine has no clinically important effect on the neuromuscular blocking action of NUROMAX.
entities: succinylcholine / NUROMAX
ddi: null
>>> match: have_VB
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: Isoflurane / NUROMAX
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: enflurane / NUROMAX
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: halothane / NUROMAX
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / antibiotics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / aminoglycosides
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / tetracyclines
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / bacitracin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / polymyxins
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / lincomycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / clindamycin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / colistin
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / sodium colistimethate
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / magnesium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / lithium
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / anesthetics
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / procainamide
ddi: effect
>>> match: include_VB
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / quinidine
ddi: effect
>>> match: include_VB
-------------
sentence: Oral doses of Antizol (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of ethanol (by approximately 40%) given to healthy volunteers in moderate doses.
entities: Antizol / ethanol
ddi: mechanism
>>> match: reduce_VB
-------------
sentence: Similarly, ethanol decreased the rate of elimination of Antizol (by approximately 50%) by the same mechanism.
entities: ethanol / Antizol
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: Pyrantel / piperazine
ddi: null
>>> match: decrease_VB
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: Antiminth / piperazine
ddi: null
>>> match: decrease_VB
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: piperazine / piperazine
ddi: null
>>> match: decrease_VB
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: pyrantel / piperazine
ddi: null
>>> match: decrease_VB
-------------
sentence: Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.
entities: Betaseron / Betaseron
ddi: null
>>> match: lead_VB
-------------
sentence: ROMAZICON blocks the central effects of benzodiazepines by competitive interaction at the receptor level.
entities: ROMAZICON / benzodiazepines
ddi: effect
>>> match: block_VB
-------------
sentence: The coadministration of aspirin decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.
entities: aspirin / fenoprofen
ddi: mechanism
>>> match: decrease_VB
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: aspirin / Nalfon
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamine's half-life and toxicity in a rat model.
entities: Cimetidine / altretamine
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / barbiturates
ddi: effect
>>> match: increase_VB
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / tolbutamide
ddi: effect
>>> match: increase_VB
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / uricosurics
ddi: effect
>>> match: increase_VB
-------------
sentence: Survanta increased the extent of dissolution of budesonide in proportion to the added concentration, which was also verified by equilibrium solubilization studies. 
entities: Survanta / budesonide
ddi: null
>>> match: increase_VB
-------------
sentence: A study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine. 
entities: vigabatrin / carbamazepine
ddi: mechanism
>>> match: cause_VB
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. 
entities: vigabatrin / phenytoin
ddi: null
>>> match: lower_VB
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. 
entities: phenytoin / phenytoin
ddi: null
>>> match: lower_VB
-------------
sentence: The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) .
entities: ENABLEX / ketoconazole
ddi: advise
>>> match: exceed_VB
-------------
sentence: The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) .
entities: ENABLEX / itraconazole
ddi: advise
>>> match: exceed_VB
-------------
sentence: The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) .
entities: ENABLEX / ritonavir
ddi: advise
>>> match: exceed_VB
-------------
sentence: The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) .
entities: ENABLEX / nelfinavir
ddi: advise
>>> match: exceed_VB
-------------
sentence: The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) .
entities: ENABLEX / clarithromycin
ddi: advise
>>> match: exceed_VB
-------------
sentence: Beta-Blocking Agents  A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Beta-Blocking Agents  A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine.
entities: metoprolol / felodipine
ddi: null
>>> match: demonstrate_VB
-------------
sentence: Tacrolimus  Felodipine may increase the blood concentration of tacrolimus.
entities: Felodipine / tacrolimus
ddi: null
>>> match: increase_VB
-------------
sentence: FLEXERIL may have life-threatening interactions with MAO inhibitors.
entities: FLEXERIL / MAO inhibitors
ddi: int
>>> match: have_VB
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / alcohol
ddi: effect
>>> match: enhance_VB
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / barbiturates
ddi: effect
>>> match: enhance_VB
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / CNS depressants
ddi: effect
>>> match: enhance_VB
-------------
sentence: Tricyclic antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds.
entities: Tricyclic antidepressants / guanethidine
ddi: effect
>>> match: block_VB
-------------
sentence: Tricyclic antidepressants may enhance the seizure risk in patients taking tramadol
entities: Tricyclic antidepressants / tramadol
ddi: effect
>>> match: enhance_VB
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: omeprazole / cilostazol
ddi: mechanism
>>> match: increase_VB
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: erythromycin / cilostazol
ddi: mechanism
>>> match: increase_VB
-------------
sentence: It was shown that neurotensin antagonized evidently the antinociceptive effect of enkephalins and their analogue. 
entities: neurotensin / enkephalins
ddi: effect
>>> match: antagonize_VB
-------------
sentence: It is concluded that neurotensin modulates in an opposite way the function of the enkephalinergic neurons and the central action of tuftsin.
entities: neurotensin / tuftsin
ddi: effect
>>> match: modulate_VB
-------------
sentence: Five days of dofetilide treatment did not significantly affect steady-state pharmacokinetic variables of digoxin compared with placebo; 
entities: dofetilide / digoxin
ddi: null
>>> match: affect_VB
-------------
sentence: therefore, the use of dofetilide does not necessitate an adjustment in digoxin dose to maintain therapeutic digoxin levels.
entities: dofetilide / digoxin
ddi: null
>>> match: necessitate_VB
-------------
sentence: Digitalis Glycosides: Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. 
entities: Diuretic / digitalis
ddi: effect
>>> match: increase_VB
-------------
sentence: Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. 
entities: Diuretic / curariform drugs
ddi: effect
>>> match: enhance_VB
-------------
sentence: Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. 
entities: Diuretic / tubocurarine
ddi: effect
>>> match: enhance_VB
-------------
sentence: Salicylates and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of MYKROX Tablets. 
entities: Salicylates / MYKROX
ddi: effect
>>> match: decrease_VB
-------------
sentence: Salicylates and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of MYKROX Tablets. 
entities: Non-Steroidal Anti-Inflammatory Drugs / MYKROX
ddi: effect
>>> match: decrease_VB
-------------
sentence: Anticoagulants: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; 
entities: Metolazone / anticoagulants
ddi: effect
>>> match: affect_VB
-------------
sentence: Anticoagulants: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; 
entities: thiazide-like diuretics / anticoagulants
ddi: null
>>> match: affect_VB
-------------
sentence: ACE inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: diminish_VB
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: reduce_VB
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: reduce_VB
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_VB
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: antacid / mefenamic acid
ddi: null
>>> match: increase_VB
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: magnesium hydroxide / mefenamic acid
ddi: null
>>> match: increase_VB
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: mefenamic acid / mefenamic acid
ddi: null
>>> match: increase_VB
-------------
sentence: Because of the small effect on half-life, the coadministration with probenecid to extend the half-life of ertapenem is not recommended.
entities: probenecid / ertapenem
ddi: advise
>>> match: extend_VB
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: ertapenem / digoxin
ddi: null
>>> match: inhibit_VB
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: ertapenem / vinblastine
ddi: null
>>> match: inhibit_VB
-------------
sentence: Concomitant treatment with thrombolytics (eg, rt-PA or streptokinase) may: - increase the risk of bleeding complications - considerably enhance the effect of REFLUDAN on aPTT prolongation
entities: thrombolytics / REFLUDAN
ddi: null
>>> match: increase_VB
-------------
sentence: Concomitant treatment with thrombolytics (eg, rt-PA or streptokinase) may: - increase the risk of bleeding complications - considerably enhance the effect of REFLUDAN on aPTT prolongation
entities: streptokinase / REFLUDAN
ddi: null
>>> match: increase_VB
-------------
sentence: Withdrawal of rifampin decreased the warfarin requirement by 50%. 
entities: rifampin / warfarin
ddi: mechanism
>>> match: decrease_VB
----------------------
1327 matches found
----------------------
P(mechanism|ANY) = 255/1327 = 0.19216277317256972
P(effect|ANY) = 347/1327 = 0.2614920874152223
P(int|ANY) = 48/1327 = 0.03617181612660136
P(advise|ANY) = 11/1327 = 0.008289374529012811
P(null|ANY) = 666/1327 = 0.5018839487565938
----------------------
P(mechanism|cause_VB) = 8/24 = 0.3333333333333333
P(effect|cause_VB) = 1/24 = 0.041666666666666664
P(null|cause_VB) = 15/24 = 0.625
P(mechanism|reduce_VB) = 28/87 = 0.3218390804597701
P(effect|reduce_VB) = 44/87 = 0.5057471264367817
P(null|reduce_VB) = 15/87 = 0.1724137931034483
P(effect|exacerbate_VB) = 1/1 = 1.0
P(effect|augment_VB) = 6/6 = 1.0
P(mechanism|inhibit_VB) = 35/65 = 0.5384615384615384
P(effect|inhibit_VB) = 8/65 = 0.12307692307692308
P(null|inhibit_VB) = 22/65 = 0.3384615384615385
P(mechanism|affect_VB) = 1/123 = 0.008130081300813009
P(effect|affect_VB) = 7/123 = 0.056910569105691054
P(null|affect_VB) = 115/123 = 0.9349593495934959
P(mechanism|decrease_VB) = 39/105 = 0.37142857142857144
P(effect|decrease_VB) = 25/105 = 0.23809523809523808
P(int|decrease_VB) = 7/105 = 0.06666666666666667
P(null|decrease_VB) = 34/105 = 0.3238095238095238
P(mechanism|increase_VB) = 50/148 = 0.33783783783783783
P(effect|increase_VB) = 36/148 = 0.24324324324324326
P(null|increase_VB) = 62/148 = 0.4189189189189189
P(mechanism|alter_VB) = 3/33 = 0.09090909090909091
P(effect|alter_VB) = 3/33 = 0.09090909090909091
P(null|alter_VB) = 27/33 = 0.8181818181818182
P(mechanism|have_VB) = 28/196 = 0.14285714285714285
P(effect|have_VB) = 19/196 = 0.09693877551020408
P(int|have_VB) = 3/196 = 0.015306122448979591
P(null|have_VB) = 146/196 = 0.7448979591836735
P(mechanism|show_VB) = 2/25 = 0.08
P(null|show_VB) = 23/25 = 0.92
P(mechanism|demonstrate_VB) = 1/21 = 0.047619047619047616
P(null|demonstrate_VB) = 20/21 = 0.9523809523809523
P(null|fibrate_VB) = 2/2 = 1.0
P(null|dose_VB) = 1/1 = 1.0
P(null|influence_VB) = 28/28 = 1.0
P(mechanism|prolong_VB) = 2/13 = 0.15384615384615385
P(effect|prolong_VB) = 6/13 = 0.46153846153846156
P(null|prolong_VB) = 5/13 = 0.38461538461538464
P(advise|useda_VB) = 1/1 = 1.0
P(advise|maintain_VB) = 1/1 = 1.0
P(mechanism|enhance_VB) = 7/77 = 0.09090909090909091
P(effect|enhance_VB) = 67/77 = 0.8701298701298701
P(null|enhance_VB) = 3/77 = 0.03896103896103896
P(mechanism|produce_VB) = 10/34 = 0.29411764705882354
P(null|produce_VB) = 24/34 = 0.7058823529411765
P(mechanism|potentiate_VB) = 3/51 = 0.058823529411764705
P(effect|potentiate_VB) = 36/51 = 0.7058823529411765
P(null|potentiate_VB) = 12/51 = 0.23529411764705882
P(mechanism|impair_VB) = 3/3 = 1.0
P(mechanism|indicate_VB) = 3/3 = 1.0
P(mechanism|induce_VB) = 7/11 = 0.6363636363636364
P(null|induce_VB) = 4/11 = 0.36363636363636365
P(mechanism|antagonize_VB) = 1/23 = 0.043478260869565216
P(effect|antagonize_VB) = 14/23 = 0.6086956521739131
P(null|antagonize_VB) = 8/23 = 0.34782608695652173
P(null|improve_VB) = 6/6 = 1.0
P(effect|counteract_VB) = 7/7 = 1.0
P(mechanism|delay_VB) = 7/11 = 0.6363636363636364
P(null|delay_VB) = 4/11 = 0.36363636363636365
P(advise|extend_VB) = 1/3 = 0.3333333333333333
P(null|extend_VB) = 2/3 = 0.6666666666666666
P(null|reveal_VB) = 1/1 = 1.0
P(mechanism|displace_VB) = 3/6 = 0.5
P(null|displace_VB) = 3/6 = 0.5
P(mechanism|bind_VB) = 4/5 = 0.8
P(null|bind_VB) = 1/5 = 0.2
P(mechanism|modify_VB) = 1/3 = 0.3333333333333333
P(null|modify_VB) = 2/3 = 0.6666666666666666
P(effect|exhibit_VB) = 2/2 = 1.0
P(effect|attenuate_VB) = 2/2 = 1.0
P(effect|accentuate_VB) = 1/1 = 1.0
P(mechanism|include_VB) = 5/80 = 0.0625
P(effect|include_VB) = 42/80 = 0.525
P(int|include_VB) = 28/80 = 0.35
P(null|include_VB) = 5/80 = 0.0625
P(effect|diminish_VB) = 6/6 = 1.0
P(mechanism|lower_VB) = 1/7 = 0.14285714285714285
P(null|lower_VB) = 6/7 = 0.8571428571428571
P(mechanism|elevate_VB) = 2/3 = 0.6666666666666666
P(null|elevate_VB) = 1/3 = 0.3333333333333333
P(effect|depress_VB) = 1/1 = 1.0
P(advise|require_VB) = 2/8 = 0.25
P(null|require_VB) = 6/8 = 0.75
P(advise|receive_VB) = 1/18 = 0.05555555555555555
P(null|receive_VB) = 17/18 = 0.9444444444444444
P(null|achieve_VB) = 2/2 = 1.0
P(effect|prevent_VB) = 3/6 = 0.5
P(null|prevent_VB) = 3/6 = 0.5
P(effect|mask_VB) = 1/1 = 1.0
P(effect|amplify_VB) = 1/1 = 1.0
P(null|contain_VB) = 2/2 = 1.0
P(null|change_VB) = 8/8 = 1.0
P(null|permit_VB) = 1/1 = 1.0
P(null|detect_VB) = 1/1 = 1.0
P(int|suggest_VB) = 10/25 = 0.4
P(null|suggest_VB) = 15/25 = 0.6
P(null|invalidate_VB) = 6/6 = 1.0
P(effect|block_VB) = 3/3 = 1.0
P(effect|experience_VB) = 3/3 = 1.0
P(effect|reverse_VB) = 1/1 = 1.0
P(null|ameliorate_VB) = 2/2 = 1.0
P(null|fluoroquinolone_VB) = 4/4 = 1.0
P(mechanism|accelerate_VB) = 1/1 = 1.0
P(null|lead_VB) = 1/1 = 1.0
P(advise|exceed_VB) = 5/5 = 1.0
P(effect|modulate_VB) = 1/1 = 1.0
P(null|necessitate_VB) = 1/1 = 1.0
